RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | adenocarcinoma |
|
Accession: | DOID:299
|
browse the term
|
Definition: | A carcinoma that has_material_basis_in abnormally proliferating cells, derives_from epithelial cells, which originate in glandular tissue. (DO) |
Synonyms: | exact_synonym: | adenocarcinomas; basal cell adenocarcinoma; basal cell adenocarcinomas; cribriform carcinoma; cribriform carcinomas; oxyphilic adenocarcinoma; oxyphilic adenocarcinomas |
| primary_id: | MESH:D000230 |
| xref: | EFO:0000228; ICDO:8140/3; NCI:C2852 |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33129824 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33129824 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Alox12b |
arachidonate 12-lipoxygenase, 12R type |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30258081 |
|
NCBI chr10:53,863,060...53,874,938
Ensembl chr10:53,863,060...53,874,938
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30258081 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Angpt2 |
angiopoietin 2 |
|
IEP |
protein:increased expression:cerebrum, blood vessels (rat) |
RGD |
PMID:10373119 |
RGD:2314294 |
NCBI chr16:71,088,364...71,138,805
Ensembl chr16:71,088,364...71,138,804
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
DNA:frameshift mutations, nonsense mutations:exon:multiple (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:9111214 PMID:15639718 PMID:11677205 |
RGD:2317202 |
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20430468 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22484628 |
|
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma |
ClinVar |
PMID:9443866 PMID:9536098 PMID:9887333 PMID:10330348 PMID:10817650 PMID:10980530 PMID:12810666 PMID:15390180 PMID:16266405 PMID:17576681 PMID:20153123 PMID:22585167 PMID:25614872 PMID:25741868 PMID:26506520 PMID:27159176 PMID:28492532 PMID:29678143 PMID:31012270 PMID:34377931 PMID:36029002 PMID:36988593 PMID:37445923 More...
|
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18978557 |
|
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26432044 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
C8h11orf65 |
similar to human chromosome 11 open reading frame 65 |
|
ISO |
ClinVar Annotator: match by term: Adenocarcinoma |
ClinVar |
PMID:9443866 PMID:9536098 PMID:9887333 PMID:10330348 PMID:10817650 PMID:10980530 PMID:12810666 PMID:15390180 PMID:16266405 PMID:17576681 PMID:20153123 PMID:22585167 PMID:25614872 PMID:25741868 PMID:26506520 PMID:27159176 PMID:28492532 PMID:29678143 PMID:31012270 PMID:34377931 PMID:36029002 PMID:36988593 PMID:37445923 More...
|
|
NCBI chr 8:53,796,033...53,825,277
Ensembl chr 8:53,796,366...53,824,748
|
|
G |
Car1 |
carbonic anhydrase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
|
|
G |
Car2 |
carbonic anhydrase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Ccn2 |
cellular communication network factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26432044 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20135361 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34973135 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Ckb |
creatine kinase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10965019 PMID:14507667 PMID:15459021 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18059332 |
|
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16142352 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp7b1 |
cytochrome P450 family 7 subfamily B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17639508 |
|
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
|
|
G |
Dapk1 |
death associated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15172992 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17571247 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21554491 |
|
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17671114 |
|
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23064031 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:2523869 PMID:20934974 PMID:21541241 PMID:22042947 PMID:27720938 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21673877 PMID:22042947 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15639718 PMID:20458558 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17639508 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fat4 |
FAT atypical cadherin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22484628 |
|
NCBI chr 2:121,927,266...122,056,700
Ensembl chr 2:121,927,942...122,056,707
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
susceptibility |
ISO |
|
RGD |
PMID:12119409 |
RGD:737746 |
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fgf9 |
fibroblast growth factor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20464547 |
|
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
|
|
G |
Gast |
gastrin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:3952654 |
|
NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
|
|
G |
Gkn1 |
gastrokine 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 4:119,790,101...119,795,389
Ensembl chr 4:119,790,101...119,795,389
|
|
G |
Gmpr2 |
guanosine monophosphate reductase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr15:29,165,421...29,175,933
Ensembl chr15:29,165,783...29,174,935
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Grb7 |
growth factor receptor bound protein 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
susceptibility |
ISO |
colon and stomach;protein:decreased activity:liver (human) |
RGD |
PMID:1988177 |
RGD:7488952 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Hdac3 |
histone deacetylase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34973135 |
|
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
|
|
G |
Hmox1 |
heme oxygenase 1 |
susceptibility |
ISO |
Lung Adenocarcinoma |
RGD |
PMID:15688187 |
RGD:1601607 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hoxa10 |
homeobox A10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21670700 |
|
NCBI chr 4:81,331,591...81,340,878
Ensembl chr 4:81,331,591...81,340,919
|
|
G |
Hrh4 |
histamine receptor H4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22363581 |
|
NCBI chr18:4,166,270...4,182,426
Ensembl chr18:4,166,270...4,246,345
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Ifna1 |
interferon, alpha 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17198089 |
|
NCBI chr 5:103,097,356...103,097,925
Ensembl chr 5:103,097,356...103,097,925
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19028472 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Kcnq1 |
potassium voltage-gated channel subfamily Q member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23975432 |
|
NCBI chr 1:198,291,711...198,624,683
Ensembl chr 1:198,291,766...198,624,669
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Kmt2a |
lysine methyltransferase 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22484628 |
|
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22484628 |
|
NCBI chr 4:9,620,638...9,834,787
Ensembl chr 4:9,609,627...9,833,539
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11745231 PMID:16247444 PMID:20101149 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Krt20 |
keratin 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,384,802...84,394,107
|
|
G |
Krt8 |
keratin 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
|
|
G |
Lta4h |
leukotriene A4 hydrolase |
|
IEP |
protein:increased expression:esophagus (rat) |
RGD |
PMID:12865451 |
RGD:2316606 |
NCBI chr 7:27,969,796...28,001,600
Ensembl chr 7:27,969,789...28,001,600
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20934974 PMID:22042947 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19028472 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mpp1 |
MAGUK p55 scaffold protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
|
|
G |
Msln |
mesothelin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11751476 |
|
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18058806 PMID:33129824 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12468628 |
|
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26432044 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nat1 |
N-acetyltransferase 1 |
susceptibility |
ISO |
associated with lung neoplasm; DNA:polymorphis: : |
RGD |
PMID:11266080 |
RGD:5131865 |
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20852035 |
|
NCBI chr 3:154,738,566...154,821,395
Ensembl chr 3:154,738,581...154,818,594
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19028472 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18225537 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21977915 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19336973 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15877079 |
|
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
|
|
G |
Pcna |
proliferating cell nuclear antigen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19028472 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
|
|
G |
Pgr |
progesterone receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15639718 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Phb1 |
prohibitin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22484628 |
|
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10467400 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Plce1 |
phospholipase C, epsilon 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20729852 |
|
NCBI chr 1:236,243,445...236,552,571
Ensembl chr 1:236,244,683...236,551,438
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11034103 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkd1 |
protein kinase D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25240283 |
|
NCBI chr 6:67,725,193...68,039,002
Ensembl chr 6:67,725,905...68,039,042
|
|
G |
Prl |
prolactin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:6280079 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17909629 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptger1 |
prostaglandin E receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11751431 |
|
NCBI chr19:24,470,258...24,473,687
Ensembl chr19:24,467,532...24,473,559
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
IMP ISO |
associated with Esophageal Neoplasms CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:10485483 PMID:16820089 PMID:17675820 |
RGD:1642603 |
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26432044 |
|
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
|
|
G |
Pycard |
PYD and CARD domain containing |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16778195 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Ramp2 |
receptor activity modifying protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17671114 |
|
NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829
|
|
G |
Rarb |
retinoic acid receptor, beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14656941 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rassf1 |
Ras association domain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15639718 |
|
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34973135 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Robo1 |
roundabout guidance receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17671114 |
|
NCBI chr11:10,580,863...11,621,675
Ensembl chr11:10,580,908...11,620,203
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
|
|
G |
Selenbp1 |
selenium binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14991897 PMID:15378696 |
|
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
|
|
G |
Serpina1 |
serpin family A member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Smarcc1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 8:110,111,097...110,214,734
Ensembl chr 8:110,111,122...110,214,720
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12907644 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sphk1 |
sphingosine kinase 1 |
|
IEP |
protein, mRNA:increased expression:colon mucosa (rat) |
RGD |
PMID:16319132 |
RGD:2311380 |
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20495387 PMID:21552421 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19028472 PMID:26432044 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20235097 PMID:21552421 |
|
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17676035 |
|
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
|
|
G |
Strap |
serine/threonine kinase receptor associated protein |
|
ISO |
|
RGD |
PMID:16778189 |
RGD:1581429 |
NCBI chr 4:170,646,042...170,660,291
Ensembl chr 4:170,646,001...170,660,828
|
|
G |
Sycp1 |
synaptonemal complex protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14991579 |
|
NCBI chr 2:190,296,688...190,456,687
Ensembl chr 2:190,296,954...190,456,737
|
|
G |
Tcf7l2 |
transcription factor 7 like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21892161 |
|
NCBI chr 1:254,785,956...254,978,967
Ensembl chr 1:254,786,091...254,978,967
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17418594 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:1733439 PMID:19028472 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic ClinVar Annotator: match by term: Adenocarcinoma |
CTD ClinVar |
PMID:1565143 PMID:1591732 PMID:2046748 PMID:4122735 PMID:7565304 PMID:7783166 PMID:7955072 PMID:8550239 PMID:8718514 PMID:9218725 PMID:9242456 PMID:9364015 PMID:9667734 PMID:10519380 PMID:10797276 PMID:10922393 PMID:11370630 PMID:11782540 PMID:11798837 PMID:12826609 PMID:12885464 PMID:12917626 PMID:15722483 PMID:15781620 PMID:15925506 PMID:15951970 PMID:16247444 PMID:16401470 PMID:16494995 PMID:16551709 PMID:16818505 PMID:17015838 PMID:17311302 PMID:17606709 PMID:18511570 PMID:20128691 PMID:20407015 PMID:20522432 PMID:21343334 PMID:21519010 PMID:21761402 PMID:22186996 PMID:22484628 PMID:22915647 PMID:23246812 PMID:23538418 PMID:24033266 PMID:24122735 PMID:24835218 PMID:25157968 PMID:25741868 PMID:25952993 PMID:26205489 PMID:26225655 PMID:26230955 PMID:26585234 PMID:26619011 PMID:26786923 PMID:27276561 PMID:27463065 PMID:27621308 PMID:27680515 PMID:27895058 PMID:27959731 PMID:28492532 PMID:29979965 PMID:30224644 PMID:30327374 PMID:30816478 PMID:32000721 PMID:32156018 PMID:32817165 PMID:32888145 PMID:33163847 PMID:33245408 PMID:33840814 PMID:34529667 PMID:34709361 PMID:35974385 PMID:36988593 More...
|
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp63 |
tumor protein p63 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20871597 |
|
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
|
|
G |
Tpm3 |
tropomyosin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15378696 |
|
NCBI chr 2:175,517,198...175,545,014
Ensembl chr 2:175,517,226...175,545,013
|
|
G |
Tyrp1 |
tyrosinase-related protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21552421 |
|
NCBI chr 5:95,280,982...95,299,516
Ensembl chr 5:95,280,982...95,299,516
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17416778 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26432044 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vti1a |
vesicle transport through interaction with t-SNAREs 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21892161 |
|
NCBI chr 1:254,356,343...254,661,854
Ensembl chr 1:254,356,429...254,661,852
|
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
DNA:mutations (human) |
RGD |
PMID:11891193 |
RGD:2317200 |
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
|
G |
Fancf |
FA complementation group F |
disease_progression |
ISO |
DNA:hypermethylation:promoter: |
RGD |
PMID:14647419 |
RGD:11049137 |
NCBI chr 1:101,449,120...101,451,936
Ensembl chr 1:101,450,389...101,451,923
|
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
disease_progression |
ISO |
|
RGD |
PMID:29043607 |
RGD:150429712 |
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
disease_progression |
ISO |
|
RGD |
PMID:29043607 |
RGD:150429712 |
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
|
|
|
G |
Ttr |
transthyretin |
|
ISO |
protein:increased expression:lung (human) |
RGD |
PMID:26943652 |
RGD:151665207 |
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12015757 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Alk |
ALK receptor tyrosine kinase |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
|
|
NCBI chr 6:22,879,653...23,599,636
Ensembl chr 6:22,880,625...23,598,034
|
|
G |
Arid1b |
AT-rich interaction domain 1B |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
PMID:25674384 PMID:28492532 PMID:30349098 |
|
NCBI chr 1:45,567,991...45,923,644
Ensembl chr 1:45,563,623...45,923,493
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
|
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atrx |
ATRX, chromatin remodeler |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
PMID:15591283 PMID:18409179 PMID:23681356 PMID:28492532 |
|
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231345 |
|
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
exacerbates |
ISO |
mRNA:increased expression:adrenal gland (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
ameliorates |
ISO |
mRNA:increased expression:adrenal gland (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
exacerbates |
ISO |
mRNA:increased expression:adrenal gland (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Birc6 |
baculoviral IAP repeat-containing 6 |
exacerbates |
ISO |
mRNA:increased expression:adrenal gland (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 6:20,722,922...20,916,396
Ensembl chr 6:20,722,922...20,916,434
|
|
G |
Birc7 |
baculoviral IAP repeat-containing 7 |
ameliorates |
ISO |
mRNA:increased expression:adrenal gland (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 3:168,047,824...168,052,606
Ensembl chr 3:168,047,824...168,052,606
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adrenocortical carcinoma |
CTD ClinVar |
PMID:12068308 PMID:14612909 PMID:14679157 PMID:14688025 PMID:17096326 PMID:17119447 PMID:17311103 PMID:18368129 PMID:18794803 PMID:19383316 PMID:19537845 PMID:19913317 PMID:20350999 PMID:20619739 PMID:21129611 PMID:22310681 PMID:23352452 PMID:23585556 PMID:24033266 PMID:25157968 PMID:26619011 PMID:28492532 PMID:29595366 More...
|
|
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Bsg |
basigin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36574092 |
|
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
|
|
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
|
|
G |
Chek2 |
checkpoint kinase 2 |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
PMID:10617473 PMID:11053450 PMID:11298456 PMID:11390408 PMID:11461078 PMID:11571648 PMID:11719428 PMID:11901158 PMID:12049740 PMID:12533788 PMID:12805407 PMID:15095295 PMID:15239132 PMID:15492928 PMID:15649950 PMID:15810020 PMID:16574953 PMID:16816021 PMID:16835864 PMID:17085682 PMID:17517688 PMID:18085035 PMID:18281249 PMID:18725978 PMID:18930998 PMID:19782031 PMID:19876921 PMID:21356067 PMID:21514219 PMID:21778326 PMID:21876083 PMID:22419737 PMID:22799331 PMID:22811390 PMID:22901170 PMID:23296741 PMID:23713947 PMID:24506336 PMID:24599715 PMID:24713400 PMID:24728327 PMID:24880342 PMID:25503501 PMID:25583358 PMID:25741868 PMID:25798211 PMID:26083025 PMID:26467025 PMID:26687385 PMID:26845104 PMID:27296296 PMID:27318168 PMID:27433846 PMID:27488870 PMID:27595995 PMID:27616075 PMID:27621404 PMID:27632928 PMID:27696107 PMID:27711073 PMID:27716369 PMID:27751358 PMID:27782108 PMID:27783279 PMID:27878467 PMID:28492532 PMID:29978187 PMID:30441849 PMID:30580288 PMID:30672594 PMID:30851065 PMID:31050813 PMID:31159747 PMID:31844177 PMID:32243226 PMID:32255556 PMID:33670479 PMID:33986034 PMID:34903604 PMID:36222830 PMID:37490054 More...
|
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adrenal cortex carcinoma | ClinVar Annotator: match by term: Adrenocortical carcinoma |
CTD ClinVar |
PMID:9065403 PMID:9500465 PMID:9927029 PMID:10027390 PMID:10192393 PMID:10398436 PMID:10435629 PMID:10655994 PMID:11351304 PMID:11930117 PMID:11950921 PMID:12124804 PMID:15133491 PMID:23265383 PMID:24747642 PMID:24788118 PMID:25157968 PMID:25741868 PMID:26619011 PMID:26822237 More...
|
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Daxx |
death-domain associated protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23585556 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Faf1 |
Fas associated factor 1 |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
|
|
NCBI chr 5:124,426,032...124,790,014
Ensembl chr 5:124,426,062...124,789,977
|
|
G |
Gnas |
GNAS complex locus |
|
ISO |
ClinVar Annotator: match by term: Adrenocortical carcinoma |
ClinVar |
PMID:1517386 PMID:1594625 PMID:1944469 PMID:2549426 PMID:3720010 PMID:7739708 PMID:8766942 PMID:9626141 PMID:10571700 PMID:11093740 PMID:12727968 PMID:12970318 PMID:15126527 PMID:15952988 PMID:16507630 PMID:16543670 PMID:17873334 PMID:20197676 PMID:21835143 PMID:23403822 PMID:23536913 PMID:23843956 PMID:24855271 PMID:25157968 PMID:25719192 PMID:25741868 PMID:26341786 PMID:26574629 PMID:26619011 PMID:27398169 PMID:27506760 PMID:28492532 PMID:29991465 PMID:30702195 More...
|
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
H3f3a |
H3.3 histone A |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
PMID:26619011 |
|
NCBI chr13:92,533,289...92,544,902
Ensembl chr13:92,533,298...92,544,908
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22407999 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21521927 PMID:23417626 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Insl6 |
insulin-like 6 |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
|
|
NCBI chr 1:227,069,958...227,073,493
Ensembl chr 1:227,069,958...227,073,493
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
|
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Kmt2a |
lysine methyltransferase 2A |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
PMID:22795537 PMID:25356970 PMID:25741868 PMID:25810209 PMID:27959697 PMID:28330790 PMID:28492532 PMID:28600779 PMID:29574747 More...
|
|
NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
|
|
G |
Med12 |
mediator complex subunit 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr X:66,404,807...66,427,775
Ensembl chr X:66,404,760...66,428,387
|
|
G |
Men1 |
menin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr 1:203,638,905...203,644,871
Ensembl chr 1:203,639,000...203,644,871
|
|
G |
Mlh1 |
mutL homolog 1 |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
|
|
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
|
|
G |
Msh6 |
mutS homolog 6 |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
|
|
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Adrenocortical carcinoma |
ClinVar |
PMID:1654209 PMID:2278970 PMID:2674680 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:15899789 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18948947 PMID:19075190 PMID:19657110 PMID:19880792 PMID:19966803 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21107323 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:23076151 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:25741868 PMID:26619011 PMID:26821351 PMID:27050078 PMID:28492532 PMID:28780248 More...
|
|
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma | ClinVar Annotator: match by term: Adrenocortical carcinoma |
ClinVar |
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:16906227 PMID:16930767 PMID:17376864 PMID:17673550 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19903786 PMID:20453058 PMID:20593314 PMID:20619739 PMID:21430269 PMID:21558396 PMID:21824802 PMID:22162582 PMID:22162589 PMID:22271473 PMID:22370636 PMID:22658544 PMID:22729222 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23946963 PMID:24033266 PMID:24782230 PMID:25157968 PMID:25599672 PMID:25681199 PMID:25741868 PMID:26266975 PMID:26266985 PMID:26619011 PMID:26627007 PMID:26822237 PMID:27126994 PMID:27626068 PMID:27631024 PMID:28492532 PMID:29446767 PMID:29988677 PMID:31536475 PMID:31775759 PMID:34008892 PMID:34496175 PMID:34568242 PMID:34606700 PMID:37667289 PMID:37712948 More...
|
|
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Rad52 |
RAD52 homolog, DNA repair protein |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
|
|
NCBI chr 4:153,106,062...153,128,598
Ensembl chr 4:153,106,062...153,128,207
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22547773 |
|
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
|
|
G |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
|
ISO |
ClinVar Annotator: match by term: Adrenal cortex carcinoma |
ClinVar |
|
|
NCBI chr 8:20,167,717...20,258,975
Ensembl chr 8:20,167,717...20,258,975
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22156929 |
|
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Top2a |
DNA topoisomerase II alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23533247 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Adrenal cortex carcinoma | ClinVar Annotator: match by term: Adrenocortical carcinoma |
CTD ClinVar |
PMID:253702 PMID:1349102 PMID:1565143 PMID:1565144 PMID:1631137 PMID:1683921 PMID:1849234 PMID:1918170 PMID:1978757 PMID:2046748 PMID:6736287 PMID:7624116 PMID:7651740 PMID:7707106 PMID:7731702 PMID:7732013 PMID:7750099 PMID:7761089 PMID:7885831 PMID:7887414 PMID:8001119 PMID:8023157 PMID:8062826 PMID:8080050 PMID:8118819 PMID:8164043 PMID:8308926 PMID:8423216 PMID:8479749 PMID:8631304 PMID:8649776 PMID:8649785 PMID:8843196 PMID:8869100 PMID:9020384 PMID:9157982 PMID:9242456 PMID:9290701 PMID:9399838 PMID:9407971 PMID:9525742 PMID:9546439 PMID:9569050 PMID:9572492 PMID:9582268 PMID:9662334 PMID:9667734 PMID:9704930 PMID:9704931 PMID:9815696 PMID:10064694 PMID:10229196 PMID:10411893 PMID:10432928 PMID:10486318 PMID:10567903 PMID:10589545 PMID:10761705 PMID:10797439 PMID:10864200 PMID:10871862 PMID:10922393 PMID:10980596 PMID:11051239 PMID:11051241 PMID:11139324 PMID:11152481 PMID:11180592 PMID:11429705 PMID:11479205 PMID:11782540 PMID:11793474 PMID:11896595 PMID:12034820 PMID:12509279 PMID:12672316 PMID:12695689 PMID:12826609 PMID:12901974 PMID:12917626 PMID:14559903 PMID:14584079 PMID:14743206 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15381368 PMID:15390294 PMID:15541116 PMID:15580553 PMID:15607980 PMID:15607981 PMID:15722483 PMID:15951970 PMID:15982667 PMID:16199547 PMID:16247456 PMID:16401470 PMID:16474844 PMID:16489069 PMID:16494995 PMID:16508005 PMID:16682957 PMID:16736287 PMID:16754663 PMID:16778209 PMID:16818505 PMID:16861262 PMID:17015838 PMID:17308077 PMID:17401428 PMID:17540308 PMID:17541742 PMID:17567834 PMID:17606709 PMID:17636407 PMID:17724467 PMID:17974978 PMID:18208484 PMID:18307025 PMID:18413811 PMID:18511570 PMID:18555592 PMID:18685109 PMID:18818522 PMID:18937320 PMID:18989156 PMID:19101993 PMID:19147582 PMID:19336573 PMID:19367569 PMID:19454241 PMID:19468865 PMID:19556618 PMID:19681600 PMID:19850740 PMID:19913028 PMID:20028212 PMID:20113312 PMID:20127978 PMID:20128691 PMID:20407015 PMID:20505364 PMID:20506564 PMID:20516128 PMID:20522432 PMID:20538734 PMID:20589832 PMID:20593220 PMID:20693561 PMID:20805372 PMID:21080251 PMID:21113594 PMID:21118481 PMID:21159183 PMID:21187651 PMID:21188122 PMID:21232794 PMID:21305319 PMID:21343334 PMID:21356188 PMID:21445056 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21535297 PMID:21552135 PMID:21601526 PMID:21626334 PMID:21761402 PMID:22110706 PMID:22186996 PMID:22484423 PMID:22507745 PMID:22710932 PMID:22768918 PMID:22811390 PMID:22822097 PMID:22869713 PMID:22915647 PMID:22923379 PMID:22983585 PMID:23161690 PMID:23246812 PMID:23259501 PMID:23484829 PMID:23538418 PMID:23585556 PMID:23630318 PMID:23894400 PMID:23897043 PMID:23967324 PMID:24033266 PMID:24065105 PMID:24076587 PMID:24381225 PMID:24384472 PMID:24487413 PMID:24501221 PMID:24573247 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24728327 PMID:24747642 PMID:24810334 PMID:24940547 PMID:25131192 PMID:25157968 PMID:25256166 PMID:25339994 PMID:25404506 PMID:25503501 PMID:25584008 PMID:25584637 PMID:25612911 PMID:25741868 PMID:25765855 PMID:25787918 PMID:25896519 PMID:25952993 PMID:25961455 PMID:26014290 PMID:26066407 PMID:26230955 PMID:26270727 PMID:26332594 PMID:26425688 PMID:26467025 PMID:26556299 PMID:26585234 PMID:26619011 PMID:26681312 PMID:26681682 PMID:26822237 PMID:26845104 PMID:27022024 PMID:27276561 PMID:27328919 PMID:27374712 PMID:27463065 PMID:27501770 PMID:27533082 PMID:27657329 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27754743 PMID:27813088 PMID:27895058 PMID:27959731 PMID:27993330 PMID:28135145 PMID:28152038 PMID:28369373 PMID:28453743 PMID:28492532 PMID:28724667 PMID:28861920 PMID:28873162 PMID:28961258 PMID:29070607 PMID:29076966 PMID:29478780 PMID:29489754 PMID:29752822 PMID:29753700 PMID:29979965 PMID:30076369 PMID:30128536 PMID:30216591 PMID:30224644 PMID:30287823 PMID:30299350 PMID:30311369 PMID:30327374 PMID:30352134 PMID:30374176 PMID:30630526 PMID:30709381 PMID:30720243 PMID:30816478 PMID:30840781 PMID:31016814 PMID:31050713 PMID:31105275 PMID:31119730 PMID:31206626 PMID:31748977 PMID:31775759 PMID:31882575 PMID:32000721 PMID:32019277 PMID:32164171 PMID:32401780 PMID:32552660 PMID:32658383 PMID:32817165 PMID:32906206 PMID:33208383 PMID:33332384 PMID:33372952 PMID:33471991 PMID:33818021 PMID:34240179 PMID:34675114 PMID:34793666 PMID:35033608 PMID:35127508 PMID:35264596 PMID:35306447 PMID:35938033 PMID:36988593 More...
|
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
ameliorates |
ISO |
mRNA:increased expression:adrenal gland (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
G |
Znrf3 |
zinc and ring finger 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24747642 |
|
NCBI chr14:80,157,854...80,313,456
Ensembl chr14:80,160,278...80,313,485
|
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
|
IEP |
associated with estrogen excess;protein:increased activity;liver (rat) |
RGD |
PMID:6133380 |
RGD:152998935 |
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
IEP |
associated with estrogen excess;protein:increased activity;liver (rat) |
RGD |
PMID:6133380 |
RGD:152998935 |
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
ISO |
|
RGD |
PMID:18059332 |
RGD:13782259 |
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
ISO |
DNA:hypermethylation DNA:hypermethylation:promoter |
RGD |
PMID:16229808 PMID:18664505 |
RGD:151665354, RGD:151665749 |
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gpx7 |
glutathione peroxidase 7 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:18664505 |
RGD:151665749 |
NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004
|
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:24131658 |
RGD:151361287 |
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Breast adenocarcinoma, somatic |
ClinVar |
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 PMID:18954143 PMID:19418217 PMID:19487299 PMID:19853286 PMID:20233444 PMID:20453058 PMID:21464312 PMID:21512767 PMID:21793738 PMID:22538770 PMID:22610119 PMID:22722201 PMID:22722839 PMID:22980975 PMID:23237847 PMID:23348505 PMID:23700467 PMID:23728071 PMID:23934607 PMID:24190505 PMID:24657128 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28492532 More...
|
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
treatment |
ISO |
|
RGD |
PMID:8589721 |
RGD:126925966 |
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Cat |
catalase |
|
ISO |
|
RGD |
PMID:25050522 |
RGD:9226881 |
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccne1 |
cyclin E1 |
|
ISO |
DNA:amplification |
RGD |
PMID:18089785 |
RGD:2289225 |
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccng1 |
cyclin G1 |
|
ISO |
mRNA, protein:altered expression:mammary (mouse) |
RGD |
PMID:11146550 |
RGD:2315939 |
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
IEP |
mRNA:increased expression:mammary epithelium (rat) |
RGD |
PMID:11097088 |
RGD:7829735 |
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
no_association |
ISO |
|
RGD |
PMID:11466624 |
RGD:2289868 |
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
H19 |
H19 imprinted maternally expressed transcript |
|
ISO |
mRNA:increased expression:breast |
RGD |
PMID:9811352 |
RGD:2306185 |
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Breast adenocarcinoma, somatic |
ClinVar |
PMID:2278970 PMID:2547513 PMID:3122217 PMID:3627975 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16434492 PMID:16618717 PMID:17332249 PMID:17384584 PMID:18316791 PMID:18794081 PMID:19018267 PMID:19075190 PMID:19114683 PMID:19255327 PMID:19679400 PMID:19773371 PMID:20921462 PMID:20921465 PMID:20978259 PMID:21063026 PMID:21228335 PMID:21398618 PMID:21975775 PMID:22392911 PMID:22407852 PMID:22571758 PMID:22734028 PMID:23182985 PMID:23406027 PMID:24033266 PMID:24558511 PMID:24720724 PMID:25157968 PMID:25705018 PMID:25741868 PMID:25808193 PMID:26623049 PMID:28492532 More...
|
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Ksr1 |
kinase suppressor of ras 1 |
severity |
ISO |
|
RGD |
PMID:24909178 |
RGD:127229932 |
NCBI chr10:63,961,771...64,098,076
Ensembl chr10:63,961,759...64,098,076
|
|
G |
Muc1 |
mucin 1, cell surface associated |
|
ISO |
mRNA,protein:increased expression:breast |
RGD |
PMID:7678777 |
RGD:2324855 |
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Mxi1 |
MAX interactor 1, dimerization protein |
|
IAGP |
|
RGD |
PMID:10849326 |
RGD:1298988 |
NCBI chr 1:252,323,915...252,383,682
Ensembl chr 1:252,323,303...252,383,681
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
ClinVar Annotator: match by term: Breast adenocarcinoma, somatic |
ClinVar |
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:15930273 PMID:16906227 PMID:16930767 PMID:17673550 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19903786 PMID:20453058 PMID:20593314 PMID:20619739 PMID:21078999 PMID:21430269 PMID:21558396 PMID:22162582 PMID:22162589 PMID:22271473 PMID:22370636 PMID:22658544 PMID:22729222 PMID:22729223 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23888070 PMID:23946963 PMID:24782230 PMID:25157968 PMID:25599672 PMID:25681199 PMID:25741868 PMID:25880439 PMID:26266975 PMID:26266985 PMID:26619011 PMID:26627007 PMID:26637981 PMID:26822237 PMID:27126994 PMID:27626068 PMID:27631024 PMID:28151489 PMID:28425981 PMID:29446767 PMID:29661094 PMID:29988677 PMID:30376034 PMID:30543347 PMID:31536475 PMID:31775759 PMID:34008892 PMID:34496175 PMID:34568242 PMID:34606700 PMID:37667289 PMID:37712948 More...
|
|
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Rb1cc1 |
RB1-inducible coiled-coil 1 |
|
ISO |
ClinVar Annotator: match by term: Breast adenocarcinoma |
ClinVar |
PMID:12068296 |
|
NCBI chr 5:13,161,648...13,225,560
Ensembl chr 5:13,161,648...13,225,560
|
|
G |
Slc22a18 |
solute carrier family 22, member 18 |
|
ISO |
ClinVar Annotator: match by term: Breast adenocarcinoma |
ClinVar |
PMID:9520460 |
|
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
human protein in a rat model |
RGD |
PMID:12536235 |
RGD:14995452 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
ClinVar Annotator: match by term: Breast adenocarcinoma, somatic |
ClinVar RGD |
PMID:1673792 PMID:1686725 PMID:7881428 PMID:8364550 PMID:10713666 PMID:11479205 PMID:11896595 PMID:11920959 PMID:12826609 PMID:16861262 PMID:17606709 PMID:20128691 PMID:20522432 PMID:21343334 PMID:23625637 PMID:25503501 PMID:25584008 PMID:25741868 PMID:26619011 PMID:28492532 PMID:29324801 PMID:29470806 PMID:29752822 PMID:29979965 PMID:30224644 PMID:30630526 PMID:33372952 PMID:11146550 More...
|
RGD:2315939 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Abcc9 |
ATP binding cassette subfamily C member 9 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:175,532,547...175,655,356
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Amfr |
autocrine motility factor receptor |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr19:10,996,705...11,032,260
Ensembl chr19:10,996,099...11,032,247
|
|
G |
Bcar1 |
BCAR1 scaffold protein, Cas family member |
|
ISO |
|
RGD |
PMID:11605729 |
RGD:1579979 |
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
PMID:9063749 PMID:10196379 PMID:11400546 PMID:14555511 PMID:15235020 PMID:16014699 PMID:17341484 PMID:17585057 PMID:19661094 PMID:20104584 PMID:21232165 PMID:21702907 PMID:21708019 PMID:21965345 PMID:21990134 PMID:22136207 PMID:22703879 PMID:23192404 PMID:23249957 PMID:23469205 PMID:24033266 PMID:24728327 PMID:25741868 PMID:28492532 PMID:36329109 More...
|
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
PMID:11062481 PMID:11927503 PMID:14555511 PMID:15235023 PMID:17767707 PMID:20135345 PMID:22703879 PMID:24033266 PMID:24323938 PMID:24728327 PMID:25741868 PMID:28492532 PMID:36329109 More...
|
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Bsg |
basigin |
|
ISO |
mRNA:increased expression:breast |
RGD |
PMID:9154157 |
RGD:2289059 |
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
PMID:28492532 |
|
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
PMID:26467025 PMID:27148582 PMID:28492532 |
|
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
|
|
G |
Ccdc180 |
coiled-coil domain containing 180 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 5:60,154,883...60,223,508
Ensembl chr 5:60,154,910...60,223,522
|
|
G |
Ccdc71l |
coiled-coil domain containing 71-like |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 6:48,960,020...48,964,112
Ensembl chr 6:48,960,191...48,960,841 Ensembl chr 6:48,960,191...48,960,841
|
|
G |
Cd44 |
CD44 molecule |
disease_progression |
ISO |
mRNA, protein:splice variant, increased expression:breast |
RGD |
PMID:16425351 |
RGD:2289356 |
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cnnm1 |
cyclin and CBS domain divalent metal cation transport mediator 1 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 1:242,296,367...242,354,957
Ensembl chr 1:242,296,422...242,353,513
|
|
G |
Coro6 |
coronin 6 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659
|
|
G |
Cpamd8 |
C3 and PZP-like, alpha-2-macroglobulin domain containing 8 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 4:155,332,827...155,413,098
Ensembl chr 4:155,332,827...155,413,117
|
|
G |
Cpxm2 |
carboxypeptidase X (M14 family), member 2 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 1:186,836,797...186,947,222
Ensembl chr 1:186,836,797...186,947,220
|
|
G |
Creb3 |
cAMP responsive element binding protein 3 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 5:57,817,865...57,823,233
Ensembl chr 5:57,817,832...57,824,390
|
|
G |
Ebag9 |
estrogen receptor binding site associated antigen 9 |
severity |
ISO |
protein:increased expression:breast |
RGD |
PMID:12054692 |
RGD:2298489 |
NCBI chr 7:75,810,950...75,828,902
Ensembl chr 7:75,810,594...75,861,248
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
Htra2 |
HtrA serine peptidase 2 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 4:115,556,914...115,560,202
Ensembl chr 4:115,556,916...115,560,095
|
|
G |
Kndc1 |
kinase non-catalytic C-lobe domain containing 1 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 1:194,689,962...194,738,353
Ensembl chr 1:194,690,135...194,738,362
|
|
G |
Lrat |
lecithin retinol acyltransferase |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
|
|
G |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 1:166,345,853...166,530,575
Ensembl chr 1:166,345,859...166,471,719 Ensembl chr 1:166,345,859...166,471,719
|
|
G |
Notch3 |
notch receptor 3 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
|
|
G |
Nts |
neurotensin |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
|
|
G |
Phf24 |
PHD finger protein 24 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 5:57,143,428...57,171,054
Ensembl chr 5:57,142,632...57,168,497
|
|
G |
Plk4 |
polo-like kinase 4 |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:26439168 |
RGD:11075990 |
NCBI chr 2:123,802,527...123,820,942
Ensembl chr 2:123,802,512...123,820,942
|
|
G |
Pml |
PML nuclear body scaffold |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
|
|
G |
Rad54l |
RAD54 like |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
PMID:10362365 |
|
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
|
|
G |
Rictor |
RPTOR independent companion of MTOR, complex 2 |
|
ISO |
associated with lymphatic metastasis; protein:increased expression:breast tumor, lymph node (human) |
RGD |
PMID:20978191 |
RGD:152995469 |
NCBI chr 2:55,811,877...55,903,893
Ensembl chr 2:55,811,322...55,901,426
|
|
G |
Rnf212 |
ring finger protein 212 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr14:949,397...988,377
Ensembl chr14:949,448...987,831
|
|
G |
Rp1 |
RP1, axonemal microtubule associated |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 5:15,121,104...15,582,363
Ensembl chr 5:15,121,133...15,579,363
|
|
G |
Rrp1 |
ribosomal RNA processing 1 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr20:10,260,892...10,272,141
Ensembl chr20:10,260,870...10,272,144
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family member 1B2 |
disease_progression |
ISO |
protein:decreased expression:breast (human) |
RGD |
PMID:17760952 |
RGD:152995410 |
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
|
|
G |
Slitrk6 |
SLIT and NTRK-like family, member 6 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr15:87,563,506...87,570,125
Ensembl chr15:87,563,322...87,570,393
|
|
G |
Spen |
spen family transcriptional repressor |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 5:153,775,287...153,848,677
Ensembl chr 5:153,776,234...153,848,811
|
|
G |
Syt6 |
synaptotagmin 6 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 2:191,093,009...191,152,283
Ensembl chr 2:191,093,007...191,149,956
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
|
ISO |
mRNA:decreased expression:breast |
RGD |
PMID:17011986 |
RGD:2290492 |
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
|
|
G |
Tp73 |
tumor protein p73 |
|
ISO |
mRNA:decreased expression:breast |
RGD |
PMID:17011986 |
RGD:2290492 |
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
|
|
G |
Tspan8 |
tetraspanin 8 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 7:51,444,946...51,479,360
Ensembl chr 7:51,445,074...51,479,356
|
|
G |
Tspear |
thrombospondin-type laminin G domain and EAR repeats |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
PMID:25741868 |
|
NCBI chr20:10,771,806...10,837,419
Ensembl chr20:10,772,219...10,943,914
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
severity |
ISO |
|
RGD |
PMID:17350670 |
RGD:2315853 |
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
G |
Yeats2 |
YEATS domain containing 2 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr11:80,743,134...80,829,253
Ensembl chr11:80,743,134...80,829,208
|
|
G |
Zdbf2 |
zinc finger, DBF-type containing 2 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 9:64,672,974...64,748,446
Ensembl chr 9:64,709,880...64,744,265
|
|
G |
Zfp420 |
zinc finger protein 420 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 1:85,092,810...85,143,682
Ensembl chr 1:85,093,085...85,106,693 Ensembl chr 1:85,093,085...85,106,693
|
|
G |
Zfp473 |
zinc finger protein 473 |
|
ISO |
ClinVar Annotator: match by term: Ductal breast carcinoma |
ClinVar |
|
|
NCBI chr 1:95,222,683...95,243,328
Ensembl chr 1:95,223,433...95,243,325
|
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8389152 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8389152 |
|
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Breast lobular carcinoma |
CTD ClinVar |
PMID:8557030 PMID:9744472 PMID:15235021 PMID:17660459 PMID:20373070 PMID:25741868 PMID:26467025 PMID:28492532 PMID:30311375 PMID:36436516 PMID:36988593 More...
|
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Myh9 |
myosin, heavy chain 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28650484 |
|
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
|
|
G |
Ppp1r12b |
protein phosphatase 1, regulatory subunit 12B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28650484 |
|
NCBI chr13:46,199,418...46,397,108
Ensembl chr13:46,201,251...46,397,108
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15609129 |
|
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
|
|
G |
Tp53bp2 |
tumor protein p53 binding protein, 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28650484 |
|
NCBI chr13:94,088,769...94,145,436
Ensembl chr13:94,088,709...94,145,432
|
|
|
G |
Alx4 |
ALX homeobox 4 |
ameliorates |
ISO |
|
RGD |
PMID:24037716 |
RGD:153344522 |
NCBI chr 3:79,611,682...79,648,260
Ensembl chr 3:79,611,719...79,648,260
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:14674039 |
RGD:13434930 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
disease_progression |
ISO |
|
RGD |
PMID:19484794 |
RGD:4140940 |
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO IMP |
DNA:snp:cds:p.T790M (human) DNA:mutations:exons: protein:increased expression:tumor (human) |
RGD |
PMID:15737014 PMID:26059825 PMID:21419590 |
RGD:5131465, RGD:11075076, RGD:5131630 |
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
mRNA:decreased expression:tumor (human) |
RGD |
PMID:11948124 |
RGD:5131942 |
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
DNA:hypermethylation:promoter (human) |
RGD |
PMID:19484794 |
RGD:4140940 |
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
IMP |
DNA:mutations:cds: |
RGD |
PMID:26059825 |
RGD:11075076 |
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Mir130a |
microRNA 130a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr 3:69,822,542...69,822,629
Ensembl chr 3:69,822,542...69,822,629
|
|
G |
Mir144 |
microRNA 144 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr10:62,961,348...62,961,430
Ensembl chr10:62,961,348...62,961,430
|
|
G |
Mir19a |
microRNA 19a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr15:92,180,912...92,180,993
Ensembl chr15:92,180,912...92,180,993
|
|
G |
Mir345 |
microRNA 345 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr 6:127,754,027...127,754,122
Ensembl chr 6:127,754,027...127,754,122
|
|
G |
Mir497 |
microRNA 497 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25926378 |
|
NCBI chr10:54,951,514...54,951,582
Ensembl chr10:54,951,505...54,951,584
|
|
G |
Tp53 |
tumor protein p53 |
|
IMP |
DNA:mutations:exons: |
RGD |
PMID:26059825 |
RGD:11075076 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Alb |
albumin |
|
ISO |
protein:decreased expression:serum: |
RGD |
PMID:975003 |
RGD:11036087 |
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Eno2 |
enolase 2 |
|
ISO |
|
RGD |
PMID:17345775 |
RGD:2293739 |
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Men1 |
menin 1 |
|
ISO |
DNA:loss of heterozygosity:lung:PYGM,D11S449,D11S906(human) |
RGD |
PMID:16465412 |
RGD:2317351 |
NCBI chr 1:203,638,905...203,644,871
Ensembl chr 1:203,639,000...203,644,871
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
ISO |
DNA:hypermethylation:promoter (human) |
RGD |
PMID:12584572 |
RGD:2317635 |
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mir10a |
microRNA 10a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr10:81,283,171...81,283,280
Ensembl chr10:81,283,171...81,283,280
|
|
G |
Mir127 |
microRNA 127 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,546,215...128,546,311
Ensembl chr 6:128,546,215...128,546,311
|
|
G |
Mir136 |
microRNA 136 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,549,096...128,549,177
Ensembl chr 6:128,549,096...128,549,177
|
|
G |
Mir146a |
microRNA 146a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mir154 |
microRNA 154 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,752,947...128,753,030
Ensembl chr 6:128,752,947...128,753,030
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir193a |
microRNA 193a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
|
|
G |
Mir222 |
microRNA 222 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr X:3,428,904...3,429,006
Ensembl chr X:3,428,904...3,429,006
|
|
G |
Mir224 |
microRNA 224 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr X:150,065,088...150,065,169
Ensembl chr X:150,065,088...150,065,169
|
|
G |
Mir30a |
microRNA 30a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 9:25,737,600...25,737,670
Ensembl chr 9:25,737,600...25,737,670
|
|
G |
Mir34b |
microRNA 34b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 8:51,410,244...51,410,327
Ensembl chr 8:51,410,244...51,410,327
|
|
G |
Mir34c |
microRNA 34c |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 8:51,409,726...51,409,802
Ensembl chr 8:51,409,726...51,409,802
|
|
G |
Mir370 |
microRNA 370 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,572,257...128,572,335
Ensembl chr 6:128,572,257...128,572,335
|
|
G |
Mir409 |
microRNA 409 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,757,780...128,757,856
Ensembl chr 6:128,757,779...128,757,858
|
|
G |
Mir410 |
microRNA 410 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,758,358...128,758,433
Ensembl chr 6:128,758,354...128,758,434
|
|
G |
Mir487b |
microRNA 487b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,741,485...128,741,566
Ensembl chr 6:128,741,485...128,741,566
|
|
G |
Mir494 |
microRNA 494 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25105010 |
|
NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
|
|
G |
Reg1a |
regenerating family member 1 alpha |
|
ISO |
associated with Hypergastrinemia;DNA:missense mutations:cds:multiple (human) |
RGD |
PMID:10348814 |
RGD:9850135 |
NCBI chr 4:110,892,451...110,895,115
Ensembl chr 4:110,892,453...110,895,570
|
|
|
G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
|
ISO |
|
RGD |
PMID:2258083 |
RGD:2300391 |
NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642
|
|
G |
Tff1 |
trefoil factor 1 |
|
ISO |
mRNA, protein:increased expression:uterine cervix |
RGD |
PMID:10727981 |
RGD:2298570 |
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tfrc |
transferrin receptor |
|
ISO |
protein:increased expression:uterine cervix |
RGD |
PMID:9739406 |
RGD:2292022 |
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tp53 |
tumor protein p53 |
disease_progression |
ISO |
|
RGD |
PMID:17354237 |
RGD:2298527 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Stk11 |
serine/threonine kinase 11 |
disease_progression |
ISO |
DNA:mutations |
RGD |
PMID:12533684 |
RGD:2291947 |
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
|
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
ClinVar Annotator: match by term: Pediatric hepatocellular carcinoma |
ClinVar |
PMID:9927037 PMID:17483355 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
susceptibility |
ISO |
DNA:polymorphism:exon:c.3972C>T (human) |
RGD |
PMID:19451719 |
RGD:2317508 |
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:16292515 |
RGD:2325640 |
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Alb |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:10776430 PMID:20431764 PMID:17545000 |
RGD:2325682, RGD:2325679, RGD:2325680 |
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
protein:increased expression:bile duct |
RGD |
PMID:18507031 |
RGD:2317521 |
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Anxa2 |
annexin A2 |
disease_progression |
ISO |
|
RGD |
PMID:20493868 |
RGD:2325728 |
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa8 |
annexin A8 |
|
ISO |
|
RGD |
PMID:19376120 |
RGD:2325733 |
NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
DNA:hypermethylation:promoter DNA:loss of heterozygosity |
RGD |
PMID:15467712 PMID:10212000 |
RGD:2317198, RGD:2317205 |
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:19486127 |
RGD:2325756 |
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
|
|
G |
Asph |
aspartate-beta-hydroxylase |
|
ISO |
|
RGD |
PMID:21898484 |
RGD:6902945 |
NCBI chr 5:22,601,581...22,814,107
Ensembl chr 5:22,603,486...22,813,876
|
|
G |
Atg101 |
autophagy related 101 |
disease_progression |
ISO |
|
RGD |
PMID:35592424 |
RGD:153350091 |
NCBI chr 7:132,398,477...132,407,643
Ensembl chr 7:132,398,483...132,407,633
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 PMID:25231345 |
|
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
|
|
G |
Birc6 |
baculoviral IAP repeat-containing 6 |
ameliorates |
ISO |
mRNA:increased expression:bile duct (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 6:20,722,922...20,916,396
Ensembl chr 6:20,722,922...20,916,434
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
IAGP |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:12692057 |
RGD:11073239 |
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
onset |
ISO |
protein:decreased expression:liver |
RGD |
PMID:15619210 |
RGD:2317417 |
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 PMID:25741868 |
|
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
|
|
G |
Cycs |
cytochrome c, somatic |
|
ISO |
|
RGD |
PMID:19788692 |
RGD:2317615 |
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
ISO |
protein:increased expression:intrahepatic bile, extrahepatic bile duct (human) |
RGD |
PMID:23375797 |
RGD:151361187 |
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 PMID:28492532 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: therapeutic ClinVar Annotator: match by term: Cholangiocarcinoma |
CTD ClinVar |
PMID:17341899 PMID:18550579 PMID:24728327 PMID:25741868 PMID:28492532 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Epo |
erythropoietin |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Epor |
erythropoietin receptor |
|
IEP |
mRNA, protein:increased expression:liver |
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
disease_progression no_association |
ISO |
DNA:SNP: :g.148505302C>T (rs887569) (human) DNA:SNPs: :g.148525904C>G, (rs2302427), g.148519011C>T (rs6464926), g.148517456T>G (rs17171119) (human) |
RGD |
PMID:24179546 PMID:24179546 |
RGD:126779604, RGD:126779604 |
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
Faslg |
Fas ligand |
|
ISO |
|
RGD |
PMID:11029528 |
RGD:2317746 |
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
protein:increased expression:bile |
RGD |
PMID:11478488 |
RGD:2317765 |
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
disease_progression |
ISO |
protein:increased expression:bile ducts |
RGD |
PMID:19721413 |
RGD:2317780 |
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
|
|
G |
Gnas |
GNAS complex locus |
disease_progression |
ISO |
DNA:polymorphism:393T>C (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:22561520 PMID:17356712 |
RGD:1601377 |
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
|
RGD |
PMID:24049014 |
RGD:14700980 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
treatment |
ISO |
DNA:hypermethylation:promoter human cell line in a mouse model |
RGD |
PMID:15467712 PMID:12805482 |
RGD:2317198, RGD:14401711 |
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hdac6 |
histone deacetylase 6 |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:23370327 |
RGD:9681560 |
NCBI chr X:14,550,645...14,572,445
Ensembl chr X:14,551,044...14,572,441
|
|
G |
Hgf |
hepatocyte growth factor |
|
IEP ISO |
mRNA, protein:increased expression: : protein:increased expression:serum |
RGD |
PMID:10827151 PMID:16974053 |
RGD:2317925, RGD:2317909 |
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:12919954 PMID:18550579 PMID:22647679 PMID:24120591 PMID:25741868 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:28492532 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il19 |
interleukin 19 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:28492532 |
|
NCBI chr13:42,397,715...42,411,637
Ensembl chr13:42,399,138...42,405,473
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 PMID:25741868 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:18798553 |
RGD:2317263 |
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:9769329 PMID:10720087 PMID:11001912 PMID:11889177 PMID:12519862 PMID:12560873 PMID:12719374 PMID:15070960 PMID:15331795 PMID:15472205 PMID:16150725 PMID:16278864 PMID:17621267 PMID:17623760 PMID:18550579 PMID:15011822 PMID:28925763 More...
|
RGD:2317167, RGD:14975292 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins2 |
insulin 2 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Kcnd2 |
potassium voltage-gated channel subfamily D member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34418280 |
|
NCBI chr 4:49,775,812...50,277,746
Ensembl chr 4:49,776,246...50,277,728
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chr 4:9,620,638...9,834,787
Ensembl chr 4:9,609,627...9,833,539
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8968066 PMID:22561520 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Krt7 |
keratin 7 |
|
ISO |
|
RGD |
PMID:18393293 |
RGD:2317308 |
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
disease_progression |
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:15619210 |
RGD:2317417 |
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
disease_progression |
IEP ISO |
protein:increased expression:liver, biliary epithelium (rat) protein:increased phosphorylation:liver, carcinoma (human) |
RGD |
PMID:14656942 PMID:16818635 |
RGD:2317601, RGD:2317578 |
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mfsd4a |
major facilitator superfamily domain containing 4A |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr13:43,469,488...43,510,467
Ensembl chr13:43,469,488...43,510,467
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
ISO |
DNA:hypermethylation:promoter (human) |
RGD |
PMID:17550320 |
RGD:2317632 |
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
miRNA:increased expression:serum |
RGD |
PMID:30653586 |
RGD:21081530 |
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir192 |
microRNA 192 |
|
ISO |
RNA:increased expression:urine |
RGD |
PMID:26456596 |
RGD:41404678 |
NCBI chr 1:203,564,946...203,565,055
Ensembl chr 1:203,564,946...203,565,055
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
RNA:increased expression:urine |
RGD |
PMID:26456596 |
RGD:41404678 |
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir23b |
microRNA 23b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34418280 |
|
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
|
|
G |
Mir494 |
microRNA 494 |
severity exacerbates |
ISO |
|
RGD |
PMID:30314946 PMID:30314946 |
RGD:156420141, RGD:156420141 |
NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
disease_progression |
ISO |
|
RGD |
PMID:12903495 |
RGD:2317705 |
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
disease_progression |
IEP ISO |
protein:increased expression:bile duct |
RGD |
PMID:15213623 PMID:19629755 |
RGD:2324667, RGD:2325769 |
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO IEP |
mRNA:increased expression:bile duct protein:increased expression:bile duct |
RGD |
PMID:16463672 PMID:15213623 PMID:15213623 |
RGD:2325856, RGD:2324667, RGD:2324667 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Msln |
mesothelin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14576474 |
|
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:17201138 |
RGD:2317119 |
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Muc1 |
mucin 1, cell surface associated |
disease_progression |
ISO IEP |
protein:increased secretion:bile protein:increased expression:serum protein:increased expression:bile duct: mRNA:increased expression:bile duct |
RGD |
PMID:19055478 PMID:19260467 PMID:15213623 PMID:18081149 PMID:19639217 |
RGD:2324622, RGD:2324664, RGD:2324667, RGD:2324638, RGD:2317986 |
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Muc16 |
mucin 16, cell surface associated |
|
ISO |
associated with Opisthorchiasis;protein:increased expression:serum |
RGD |
PMID:1653472 |
RGD:2325142 |
NCBI chr 8:16,164,531...16,323,126
|
|
G |
Muc17 |
mucin 17, cell surface associated |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chr12:19,527,251...19,536,924
Ensembl chr12:19,527,321...19,538,522
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chr 1:196,799,494...196,831,740
Ensembl chr 1:196,799,517...196,831,756
|
|
G |
Muc3a |
mucin 3A, cell surface associated |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chr12:19,450,679...19,454,753
|
|
G |
Muc4 |
mucin 4, cell surface associated |
disease_progression |
ISO IEP |
protein:increased expression:bile duct |
RGD |
PMID:14752841 PMID:19082442 |
RGD:2324944, RGD:2303602 |
NCBI chr11:68,008,245...68,053,242
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
disease_progression |
ISO |
protein:increased expression:serum mRNA:increased expression:bile duct |
RGD |
PMID:14508831 PMID:11680592 |
RGD:2324990, RGD:2324948 |
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
|
|
G |
Muc6 |
mucin 6, oligomeric mucus/gel-forming |
|
ISO |
protein:increased expression: : |
RGD |
PMID:10209489 |
RGD:2325167 |
NCBI chr 1:196,726,678...196,764,842
Ensembl chr 1:196,726,807...196,764,842
|
|
G |
Nat2 |
N-acetyltransferase 2 |
|
ISO |
DNA:polymorphisms (human) |
RGD |
PMID:15901993 |
RGD:2317172 |
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
|
ISO |
associated with hepatitis |
RGD |
PMID:12031086 |
RGD:2326079 |
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:bile duct CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16818635 PMID:16094703 |
RGD:2325280 |
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch1 |
notch receptor 1 |
|
ISO |
protein:increased expression:cholangiocyte |
RGD |
PMID:15887117 |
RGD:2325330 |
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
disease_progression |
IEP |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:24255171 |
RGD:15090822 |
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
disease_progression |
ISO |
DNA:loss of heterozygosity (human) |
RGD |
PMID:11866974 PMID:11260864 |
RGD:2317134, RGD:2317136 |
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Osbp2 |
oxysterol binding protein 2 |
|
ISO |
mRNA:increased expression:blood |
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chr14:78,585,088...78,746,785
Ensembl chr14:78,585,089...78,746,786
|
|
G |
Osbpl7 |
oxysterol binding protein-like 7 |
|
ISO |
mRNA:increased expression:blood |
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chr10:82,035,995...82,053,566
Ensembl chr10:82,036,042...82,053,557
|
|
G |
Panx2 |
pannexin 2 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 7:120,139,259...120,153,056
Ensembl chr 7:120,139,294...120,152,361
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
|
ISO |
mRNA,protein:decreased expression:cholangiocyte: |
RGD |
PMID:20724592 |
RGD:9835357 |
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
|
|
G |
Pbrm1 |
polybromo 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chr16:6,213,507...6,312,895
Ensembl chr16:6,213,300...6,311,780
|
|
G |
Peg3 |
paternally expressed 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chr 1:67,097,874...67,124,692
Ensembl chr 1:67,097,904...67,124,671
|
|
G |
Pes1 |
pescadillo ribosomal biogenesis factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34845814 |
|
NCBI chr14:78,850,754...78,867,134
Ensembl chr14:78,850,709...78,867,134
|
|
G |
Pir |
pirin |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
|
|
G |
Ppia |
peptidylprolyl isomerase A |
ameliorates |
ISO |
human cell line and construct in a mouse model |
RGD |
PMID:21871105 |
RGD:150429623 |
NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
|
|
G |
Prex2 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 |
sexual_dimorphism |
ISO |
DNA:substitutions, insertion/deletions: (human) |
RGD |
PMID:28000796 |
RGD:151665188 |
NCBI chr 5:7,937,692...8,253,112
Ensembl chr 5:7,942,573...8,253,068
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Prkacb |
protein kinase cAMP-activated catalytic subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chr 2:235,636,878...235,726,928
Ensembl chr 2:235,636,885...235,726,198
|
|
G |
Prrg4 |
proline rich and Gla domain 4 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 3:91,214,646...91,243,347
Ensembl chr 3:91,214,653...91,243,273
|
|
G |
Prss2 |
protease, serine, 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:8621252 |
RGD:2324908 |
NCBI chr 4:70,278,304...70,283,385
Ensembl chr 4:70,278,304...70,283,385
|
|
G |
Prss56 |
serine protease 56 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 9:87,842,806...87,859,978
Ensembl chr 9:87,854,805...87,859,978
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:27022031 PMID:23376645 |
RGD:12802341 |
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:increased expression:bile duct ClinVar Annotator: match by term: Cholangiocarcinoma CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:16818635 PMID:19621664 |
RGD:2317180 |
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rassf8 |
Ras association domain family member 8 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 4:178,716,110...178,798,042
Ensembl chr 4:178,719,992...178,796,690
|
|
G |
Reg1a |
regenerating family member 1 alpha |
susceptibility |
ISO |
mRNA, protein:increased expression:liver (human) |
RGD |
PMID:11343228 |
RGD:10044031 |
NCBI chr 4:110,892,451...110,895,115
Ensembl chr 4:110,892,453...110,895,570
|
|
G |
Rnf39 |
ring finger protein 39 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr20:1,604,794...1,610,283
Ensembl chr20:1,604,794...1,610,283
|
|
G |
Rnf43 |
ring finger protein 43 |
exacerbates |
ISO |
CTD Direct Evidence: marker/mechanism associated with opisthorchiasis;DNA:SNPs:multiple: (human) |
CTD RGD |
PMID:22561520 PMID:22561520 |
RGD:151361227 |
NCBI chr10:72,461,508...72,537,301
Ensembl chr10:72,464,348...72,536,977
|
|
G |
Robo2 |
roundabout guidance receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
protein:decreased expression:bile duct |
RGD |
PMID:19827872 |
RGD:2324955 |
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
|
|
G |
Slc4a4 |
solute carrier family 4 member 4 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17408651 |
|
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression treatment |
ISO |
|
RGD |
PMID:25475870 PMID:28347255 PMID:24131658 |
RGD:151361214, RGD:151361294, RGD:151361287 |
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Smad4 |
SMAD family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
severity |
ISO |
protein:decreased expression:bile duct (human) |
RGD |
PMID:26485275 |
RGD:11250478 |
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sox17 |
SRY-box transcription factor 17 |
severity |
IEP |
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
disease_progression |
ISO IEP |
protein:increased expression:pancreas |
RGD |
PMID:16083599 PMID:12632524 |
RGD:2325020, RGD:1299231 |
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
|
IEP |
mRNA:increased expression:bile duct |
RGD |
PMID:12632524 |
RGD:1299231 |
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Thbs1 |
thrombospondin 1 |
disease_progression |
ISO |
DNA:hypermethylation (human) |
RGD |
PMID:11927969 PMID:12213730 PMID:16465407 |
RGD:2325027, RGD:2325026, RGD:2325024 |
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Tnc |
tenascin C |
severity |
IEP |
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
severity |
ISO |
protein:increased expression:bile duct (human) |
RGD |
PMID:26485275 |
RGD:11250478 |
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635 PMID:22561520 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Ttr |
transthyretin |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:18275060 |
RGD:151660506 |
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
|
ISO |
|
RGD |
PMID:9230212 |
RGD:2325161 |
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Wdhd1 |
WD repeat and HMG-box DNA binding protein 1 |
ameliorates |
ISO |
|
RGD |
PMID:30314946 |
RGD:156420141 |
NCBI chr15:20,478,310...20,523,106
Ensembl chr15:20,489,291...20,523,096
|
|
G |
Wnt9a |
Wnt family member 9A |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chr10:44,094,140...44,121,134
Ensembl chr10:44,094,140...44,121,133
|
|
|
G |
Fgf8 |
fibroblast growth factor 8 |
|
ISO |
testicular germ cell neoplasms |
RGD |
PMID:11764380 |
RGD:2289339 |
NCBI chr 1:244,584,477...244,590,578
Ensembl chr 1:244,584,652...244,590,359
|
|
G |
Igf2 |
insulin-like growth factor 2 |
disease_progression |
ISO |
|
RGD |
PMID:17556377 |
RGD:2290454 |
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Insr |
insulin receptor |
disease_progression |
ISO |
|
RGD |
PMID:17556377 |
RGD:2290454 |
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
mRNA:increased expression:mononuclear cytotrophoblast cell |
RGD |
PMID:8504434 |
RGD:2292200 |
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
ISO |
mRNA:increased expression:mononuclear cytotrophoblast cell |
RGD |
PMID:8504434 |
RGD:2292200 |
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
ISO |
DNA, protein:hypermethylation, decreased expression:promoter, placenta |
RGD |
PMID:15507671 |
RGD:2290418 |
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
|
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
exacerbates |
ISO |
mRNA:increased expression:kidney (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Hnf1a |
HNF1 homeobox A |
|
ISO |
RNA:decreased expression:kidney (human) ClinVar Annotator: match by term: Chromophobe renal cell carcinoma |
ClinVar RGD |
PMID:9392505 PMID:9754819 PMID:10966642 PMID:11393552 PMID:15649945 PMID:17573900 PMID:19169489 PMID:19929997 PMID:21696527 PMID:22348187 PMID:22432108 PMID:24097065 PMID:25741868 PMID:26059258 PMID:26431509 PMID:26467025 PMID:27148439 PMID:28395978 PMID:28492532 PMID:31365591 PMID:31576961 PMID:31638168 PMID:15649945 More...
|
RGD:150540316 |
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
|
|
G |
Hnf1b |
HNF1 homeobox B |
|
ISO |
ClinVar Annotator: match by term: Chromophobe renal cell carcinoma |
ClinVar |
PMID:15649945 PMID:16371430 PMID:25536396 PMID:25700310 PMID:25741868 |
|
NCBI chr10:68,735,894...68,789,888
Ensembl chr10:68,735,894...68,789,888
|
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9754764 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Cbx7 |
chromobox 7 |
disease_progression |
ISO |
|
RGD |
PMID:24375438 |
RGD:9587359 |
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
|
|
G |
Daxx |
death-domain associated protein |
|
ISO |
protein:increased expression:ovary: |
RGD |
PMID:23539629 |
RGD:9587820 |
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9754764 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
|
ISO |
mRNA:increased expression:kidney: |
RGD |
PMID:29218250 |
RGD:155804290 |
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO |
mRNA:increased expression:renal cortex (human) |
RGD |
PMID:21947243 |
RGD:7244181 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Clear cell carcinoma of kidney |
ClinVar |
PMID:8755918 PMID:9792409 PMID:10980530 PMID:18560558 PMID:19431188 PMID:19691550 PMID:19779456 PMID:25186627 PMID:25741868 PMID:26628246 PMID:28492532 PMID:29522266 PMID:33747920 More...
|
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp5mc2 |
ATP synthase membrane subunit c locus 2 |
|
ISO |
|
RGD |
PMID:28672194 |
RGD:14696810 |
NCBI chr 7:133,791,341...133,799,713
Ensembl chr 7:133,791,342...133,799,733
|
|
G |
Atp5pb |
ATP synthase peripheral stalk-membrane subunit b |
|
ISO |
|
RGD |
PMID:28672194 |
RGD:14696810 |
NCBI chr 2:193,424,138...193,435,418
Ensembl chr 2:193,424,047...193,435,418
|
|
G |
Atp5po |
ATP synthase peripheral stalk subunit OSCP |
|
ISO |
|
RGD |
PMID:28672194 |
RGD:14696810 |
NCBI chr11:31,165,218...31,171,530
Ensembl chr11:31,165,217...31,171,592
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
ClinVar Annotator: match by term: Clear cell carcinoma of kidney |
ClinVar |
PMID:25741868 PMID:28492532 PMID:35483881 PMID:35992853 |
|
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:28551630 |
RGD:15036804 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
disease_progression |
ISO |
mRNA:increased expression:kidney (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
exacerbates |
ISO |
mRNA:increased expression:kidney (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Birc6 |
baculoviral IAP repeat-containing 6 |
ameliorates |
ISO |
mRNA:increased expression:kidney (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 6:20,722,922...20,916,396
Ensembl chr 6:20,722,922...20,916,434
|
|
G |
C8h11orf65 |
similar to human chromosome 11 open reading frame 65 |
|
ISO |
ClinVar Annotator: match by term: Clear cell carcinoma of kidney |
ClinVar |
PMID:8755918 PMID:9792409 PMID:10980530 PMID:18560558 PMID:19431188 PMID:19691550 PMID:19779456 PMID:25186627 PMID:25741868 PMID:26628246 PMID:28492532 PMID:29522266 PMID:33747920 More...
|
|
NCBI chr 8:53,796,033...53,825,277
Ensembl chr 8:53,796,366...53,824,748
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
|
ISO |
mRNA:decreased expression:kidney (human) |
RGD |
PMID:28486105 |
RGD:153323299 |
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
|
ISO |
mRNA:decreased expression:kidney: |
RGD |
PMID:29218250 |
RGD:155804290 |
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
|
ISO |
mRNA:increased expression:kidney: |
RGD |
PMID:29218250 |
RGD:155804290 |
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
severity |
ISO |
mRNA, protein:decreased expression:kidney (human) mRNA:increased expression:kidney, lymph nodes (human) |
RGD |
PMID:31018949 PMID:27020590 |
RGD:151347528, RGD:151347863 |
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27292127 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27292127 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
disease_progression |
ISO |
|
RGD |
PMID:23788753 |
RGD:13506731 |
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Eng |
endoglin |
severity |
ISO |
protein:increased expression:tumor, vasculature (human) protein:decreased expression:kidney, tumor (human) |
RGD |
PMID:22204709 PMID:16536758 |
RGD:7248775, RGD:7248780 |
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
|
|
G |
Ep300 |
E1A binding protein p300 |
severity |
ISO |
mRNA:altered expression:kidney, tumor (human) mRNA, protein:increased expression:kidney |
RGD |
PMID:23029358 PMID:28551630 |
RGD:7296925, RGD:15036804 |
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:22065054 |
RGD:6893520 |
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Flt4 |
Fms related receptor tyrosine kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25239121 |
|
NCBI chr10:33,913,725...33,954,770
Ensembl chr10:33,913,608...33,954,770
|
|
G |
Fto |
FTO, alpha-ketoglutarate dependent dioxygenase |
disease_progression treatment |
ISO |
mRNA:decreased expression:kidney mRNA:increased expression:kidney |
RGD |
PMID:30648791 PMID:32817424 PMID:32817424 |
RGD:329812005, RGD:329812006, RGD:329812006 |
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
|
|
G |
Gata1 |
GATA binding protein 1 |
disease_progression |
ISO |
|
RGD |
PMID:25230694 |
RGD:149735195 |
NCBI chr X:14,529,706...14,537,530
Ensembl chr X:14,529,702...14,537,530
|
|
G |
Gata2 |
GATA binding protein 2 |
disease_progression |
ISO |
|
RGD |
PMID:25230694 |
RGD:149735195 |
NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
|
RGD |
PMID:10383153 |
RGD:6906878 |
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hnf1a |
HNF1 homeobox A |
|
ISO |
ClinVar Annotator: match by term: Clear cell carcinoma of kidney |
ClinVar |
PMID:8866553 PMID:8945470 PMID:9032114 PMID:9045858 PMID:9075818 PMID:9166684 PMID:9313763 PMID:9392505 PMID:9439666 PMID:9754819 PMID:10333057 PMID:10447526 PMID:10754480 PMID:10966642 PMID:11058894 PMID:11315851 PMID:11393552 PMID:12050210 PMID:12355088 PMID:12530534 PMID:12574234 PMID:12618559 PMID:14747304 PMID:15649945 PMID:15928245 PMID:17054605 PMID:17407387 PMID:17440016 PMID:17573900 PMID:17937063 PMID:17989309 PMID:18003757 PMID:18672310 PMID:19169489 PMID:19929997 PMID:21051477 PMID:21628466 PMID:21696527 PMID:22348187 PMID:22432108 PMID:23348805 PMID:23551881 PMID:23607861 PMID:24097065 PMID:25174781 PMID:25555642 PMID:25741868 PMID:26059258 PMID:26431509 PMID:26467025 PMID:27148439 PMID:28395978 PMID:28492532 PMID:28862987 PMID:29417725 PMID:30814848 PMID:31365591 PMID:31576961 PMID:31638168 PMID:32741144 PMID:34373539 More...
|
|
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
ISO |
xenograph of human clear cell renal cancer cells in mouse |
RGD |
PMID:19509240 |
RGD:7242921 |
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Iscu |
iron-sulfur cluster assembly enzyme |
disease_progression |
ISO |
mRNA,protein:decreased expression:kidney (human) |
RGD |
PMID:23449350 |
RGD:155260320 |
NCBI chr12:42,852,305...42,858,150
Ensembl chr12:42,852,305...42,858,150
|
|
G |
Kat8 |
lysine acetyltransferase 8 |
|
ISO |
mRNA, protein:decreased expression:kidney (human) |
RGD |
PMID:23394073 |
RGD:9586034 |
NCBI chr 1:182,524,355...182,536,638
Ensembl chr 1:182,515,327...182,536,633
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
disease_progression ameliorates |
ISO |
|
RGD |
PMID:23982215 PMID:23982215 |
RGD:151356974, RGD:151356974 |
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
|
|
G |
Mir210 |
microRNA 210 |
|
ISO |
miRNA:increased expression:kidney (human) |
RGD |
PMID:23449350 |
RGD:155260320 |
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
|
ISO |
|
RGD |
PMID:11576837 |
RGD:2290421 |
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility severity |
ISO |
DNA:transition, transversion:cds:g.677C>T, g.1298A>C (human) |
RGD |
PMID:21489764 PMID:20039875 |
RGD:6893474, RGD:6893632 |
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
severity |
ISO |
protein:increased expression:kidney (human) |
RGD |
PMID:21881486 |
RGD:7207420 |
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
ClinVar Annotator: match by term: Clear cell carcinoma of kidney |
ClinVar |
PMID:9681819 PMID:10987279 PMID:12172214 PMID:19537786 PMID:21195604 PMID:25741868 More...
|
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Pak4 |
p21 (RAC1) activated kinase 4 |
disease_progression |
ISO |
|
RGD |
PMID:25744653 |
RGD:13504816 |
NCBI chr 1:83,849,904...83,889,188
Ensembl chr 1:83,849,904...83,859,413
|
|
G |
Pak6 |
p21 (RAC1) activated kinase 6 |
disease_progression |
ISO |
|
RGD |
PMID:24715215 |
RGD:13506722 |
NCBI chr 3:105,638,248...105,674,399
Ensembl chr 3:105,638,653...105,672,975
|
|
G |
Pbrm1 |
polybromo 1 |
|
ISO |
ClinVar Annotator: match by term: Clear cell carcinoma of kidney |
ClinVar |
PMID:25911086 |
|
NCBI chr16:6,213,507...6,312,895
Ensembl chr16:6,213,300...6,311,780
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
disease_progression |
ISO |
|
RGD |
PMID:25766258 PMID:23879920 |
RGD:13504817, RGD:13506650 |
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pml |
PML nuclear body scaffold |
|
ISO |
protein:decreased expression:kidney (human) |
RGD |
PMID:25293974 |
RGD:41404694 |
NCBI chr 8:58,627,347...58,661,927
Ensembl chr 8:58,628,837...58,658,971
|
|
G |
Ppbp |
pro-platelet basic protein |
disease_progression ameliorates |
ISO |
|
RGD |
PMID:24335961 PMID:24335961 |
RGD:401794956, RGD:401794956 |
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
|
|
G |
Setd2 |
SET domain containing 2, histone lysine methyltransferase |
severity |
ISO |
DNA:SNPs,loss of heterozygosity:multiple (human) DNA:mutations:multiple (human) |
RGD |
PMID:26864202 PMID:26891804 |
RGD:150429635, RGD:150429640 |
NCBI chr 8:110,511,808...110,597,475
Ensembl chr 8:110,511,772...110,597,489
|
|
G |
Smarcb1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 |
|
ISO |
mRNA,protein:decreased expression:kidney: |
RGD |
PMID:29218250 |
RGD:155804290 |
NCBI chr20:12,741,164...12,763,616
Ensembl chr20:12,741,477...12,763,620
|
|
G |
Srsf1 |
serine and arginine rich splicing factor 1 |
|
ISO |
mRNA:altered expression:kidney (human) |
RGD |
PMID:21082031 |
RGD:11039407 |
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336
|
|
G |
Srsf2 |
serine and arginine rich splicing factor 2 |
|
ISO |
mRNA:altered expression:kidney (human) |
RGD |
PMID:21082031 |
RGD:11039407 |
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
|
|
G |
Srsf4 |
serine and arginine rich splicing factor 4 |
|
ISO |
mRNA:altered expression:kidney (human) |
RGD |
PMID:21082031 |
RGD:11039407 |
NCBI chr 5:144,060,981...144,090,798
Ensembl chr 5:144,061,463...144,089,229
|
|
G |
Srsf5 |
serine and arginine rich splicing factor 5 |
|
ISO |
mRNA:altered expression:kidney (human) |
RGD |
PMID:21082031 |
RGD:11039407 |
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
|
|
G |
Srsf6 |
serine and arginine rich splicing factor 6 |
|
ISO |
mRNA:altered expression:kidney (human) |
RGD |
PMID:21082031 |
RGD:11039407 |
NCBI chr 3:151,589,546...151,594,869
Ensembl chr 3:151,589,535...151,594,860
|
|
G |
Srsf7 |
serine and arginine rich splicing factor 7 |
|
ISO |
mRNA:altered expression:kidney (human) |
RGD |
PMID:21082031 |
RGD:11039407 |
NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
mRNA, protein:increased expression:kidney |
RGD |
PMID:28551630 |
RGD:15036804 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25239121 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
ameliorates |
ISO |
mRNA:increased expression:kidney (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
|
G |
Abhd5 |
abhydrolase domain containing 5, lysophosphatidic acid acyltransferase |
disease_progression |
ISO |
human cells in mouse model mRNA:decreased expression:colon (human) |
RGD |
PMID:30842415 PMID:30842415 |
RGD:153002829, RGD:153002829 |
NCBI chr 8:122,000,241...122,026,447
Ensembl chr 8:122,000,389...122,026,447
|
|
G |
Anxa7 |
annexin A7 |
|
ISO |
protein:decreased expression:colon |
RGD |
PMID:17708571 |
RGD:2292654 |
NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
IMP ISO |
associated with Adenomatous Polyposis Coli;DNA:point mutation:CDS:p.K1137X (3409A>T) (rat) ClinVar Annotator: match by term: Colon adenocarcinoma |
ClinVar RGD |
PMID:24033266 PMID:24728327 PMID:25741868 PMID:27978560 PMID:28492532 PMID:17360473 More...
|
RGD:1601201 |
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
ApcPirc |
APC, WNT signaling pathway regulator; polyposis in the rat colon |
|
IMP |
associated with Adenomatous Polyposis Coli |
RGD |
PMID:17360473 |
RGD:1601201 |
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
disease_progression |
ISO |
protein:decreased expression:colorectum (human) |
RGD |
PMID:26980037 |
RGD:126790569 |
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
susceptibility |
ISO |
DNA:frameshift mutation: ; |
RGD |
PMID:9020077 |
RGD:734633 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
ISO |
human cells in mouse model |
RGD |
PMID:32504672 |
RGD:125097526 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Btk |
Bruton tyrosine kinase |
|
ISO |
mRNA:decreased expression:colon (human) |
RGD |
PMID:31402962 |
RGD:151347853 |
NCBI chr X:97,722,796...97,762,315
Ensembl chr X:97,722,802...97,761,853
|
|
G |
Cacna1d |
calcium voltage-gated channel subunit alpha1 D |
disease_progression |
ISO |
protein:increased expression:colon (human) |
RGD |
PMID:29079724 |
RGD:152177516 |
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
|
|
G |
Calr |
calreticulin |
|
ISO |
|
RGD |
PMID:18812201 |
RGD:150521683 |
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Car12 |
carbonic anhydrase 12 |
disease_progression |
ISO |
|
RGD |
PMID:35847888 |
RGD:153352327 |
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
ameliorates |
ISO |
human cells in a mouse model |
RGD |
PMID:28486105 |
RGD:153323299 |
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
ameliorates |
ISO |
mouse cell line in a mouse model human cells in a mouse model |
RGD |
PMID:29436396 PMID:24898549 PMID:32304779 |
RGD:150524289, RGD:150524303, RGD:150524290 |
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf2 |
colony stimulating factor 2 |
treatment |
ISO |
|
RGD |
PMID:10830715 |
RGD:10450245 |
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
IAGP |
DNA:mutation |
RGD |
PMID:16886601 |
RGD:1599637 |
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
ISO |
mRNA:increased expression:colonic mucosa (human) |
RGD |
PMID:27793774 |
RGD:151665173 |
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Daxx |
death-domain associated protein |
|
ISO |
protein:decreased expression:colon: |
RGD |
PMID:16569639 |
RGD:9587838 |
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
ISO |
protein:increased expression:colon(human) |
RGD |
PMID:19360331 |
RGD:153298969 |
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
|
|
G |
Fech |
ferrochelatase |
|
ISO |
mRNA:decreased expression:colon |
RGD |
PMID:28075030 |
RGD:14700888 |
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
|
ISO |
protein:increased expression:colon (human) |
RGD |
PMID:22419013 |
RGD:153344572 |
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
|
ISO |
protein:increased expression:colon (human) |
RGD |
PMID:22419013 |
RGD:153344572 |
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
|
|
G |
Foxa1 |
forkhead box A1 |
|
ISO |
mRNA:decreased expression:colon |
RGD |
PMID:32839292 |
RGD:151665753 |
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Gata1 |
GATA binding protein 1 |
|
ISO |
|
RGD |
PMID:31069596 |
RGD:149735196 |
NCBI chr X:14,529,706...14,537,530
Ensembl chr X:14,529,702...14,537,530
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
IEP |
|
RGD |
PMID:20616616 |
RGD:10402080 |
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Il21 |
interleukin 21 |
treatment |
ISO |
|
RGD |
PMID:17695518 |
RGD:127285540 |
NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
|
|
G |
Jak2 |
Janus kinase 2 |
treatment ameliorates |
ISO |
Human cell in mouse model human cells in mouse model |
RGD |
PMID:32504672 PMID:22050790 |
RGD:125097526, RGD:127285665 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Kdm6a |
lysine demethylase 6A |
|
ISO |
DNA:hypermethylation |
RGD |
PMID:33174323 |
RGD:150429730 |
NCBI chr X:4,337,466...4,477,100
Ensembl chr X:4,337,750...4,477,062
|
|
G |
Lox |
lysyl oxidase |
ameliorates |
ISO |
|
RGD |
PMID:21282564 |
RGD:150520218 |
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
|
|
G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
ISO |
human cell line and gene in a mouse model |
RGD |
PMID:18436711 |
RGD:155630593 |
NCBI chr12:2,591,312...2,600,534
Ensembl chr12:2,591,219...2,604,222
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
|
ISO |
|
RGD |
PMID:24691442 |
RGD:13210775 |
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
|
ISO |
|
RGD |
PMID:24691442 |
RGD:13210775 |
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
IEP |
mRNA:decreased expression:colon (rat) |
RGD |
PMID:16886601 |
RGD:1599637 |
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mir155 |
microRNA 155 |
treatment |
ISO |
|
RGD |
PMID:29535520 |
RGD:21409754 |
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
protein:increased expression:colon (human) |
RGD |
PMID:22419013 |
RGD:153344572 |
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:colon (human) |
RGD |
PMID:22419013 |
RGD:153344572 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Msh6 |
mutS homolog 6 |
|
ISO |
ClinVar Annotator: match by term: Colon adenocarcinoma |
ClinVar |
PMID:25741868 |
|
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
exacerbates |
ISO |
human cell line in a mouse model |
RGD |
PMID:18538140 |
RGD:150521533 |
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Naip6 |
NLR family, apoptosis inhibitory protein 6 |
exacerbates |
ISO |
mRNA:increased expression:colon (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 2:31,507,423...31,559,098
Ensembl chr 2:31,507,424...31,570,542
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:colon (human) |
RGD |
PMID:22419013 |
RGD:153344572 |
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Pcsk5 |
proprotein convertase subtilisin/kexin type 5 |
|
ISO |
mRNA:decreased expression:colon: |
RGD |
PMID:19737405 |
RGD:11556207 |
NCBI chr 1:214,837,847...215,267,626
Ensembl chr 1:214,837,927...215,267,600
|
|
G |
Pfas |
phosphoribosylformylglycinamidine synthase |
|
ISO |
|
RGD |
PMID:6722784 |
RGD:5135276 |
NCBI chr10:53,690,301...53,711,811
Ensembl chr10:53,691,626...53,708,420
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
DNA:mutation |
RGD |
PMID:17575153 |
RGD:5685670 |
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
treatment |
ISO |
|
RGD |
PMID:24632606 |
RGD:13432053 |
NCBI chr 5:129,700,925...129,772,591
Ensembl chr 5:129,701,229...129,772,583
|
|
G |
Rac1 |
Rac family small GTPase 1 |
treatment |
ISO |
mRNA:alternative form |
RGD |
PMID:10597294 PMID:19561401 |
RGD:13432049, RGD:13432051 |
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Rad54l |
RAD54 like |
|
ISO |
ClinVar Annotator: match by term: Colon adenocarcinoma |
ClinVar |
PMID:10362365 |
|
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
|
|
G |
Rnasel |
ribonuclease L |
severity |
ISO |
|
RGD |
PMID:23567782 |
RGD:40902808 |
NCBI chr13:65,894,990...65,910,354
Ensembl chr13:65,901,459...65,908,704
|
|
G |
Rnaset2 |
ribonuclease T2 |
|
ISO |
human cells in mouse model |
RGD |
PMID:30842415 |
RGD:153002829 |
NCBI chr 1:52,576,344...52,603,151
Ensembl chr 1:52,585,929...52,603,147
|
|
G |
Slc22a18 |
solute carrier family 22, member 18 |
ameliorates |
ISO |
mRNA:decreased expression:colorectum (human) |
RGD |
PMID:26196590 |
RGD:11522474 |
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
|
|
G |
Smc2 |
structural maintenance of chromosomes 2 |
severity |
ISO |
human cell line in a mouse model |
RGD |
PMID:23095742 |
RGD:151356955 |
NCBI chr 5:66,806,882...66,853,478
Ensembl chr 5:66,807,011...66,853,242
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
ameliorates |
ISO |
|
RGD |
PMID:21282564 |
RGD:150520218 |
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srsf4 |
serine and arginine rich splicing factor 4 |
|
ISO |
mRNA:decreased expression:colon mucosa (human) |
RGD |
PMID:9865741 |
RGD:11039405 |
NCBI chr 5:144,060,981...144,090,798
Ensembl chr 5:144,061,463...144,089,229
|
|
G |
Srsf5 |
serine and arginine rich splicing factor 5 |
|
ISO |
mRNA:decreased expression:colon mucosa (human) |
RGD |
PMID:9865741 |
RGD:11039405 |
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
|
|
G |
Srsf6 |
serine and arginine rich splicing factor 6 |
|
ISO |
mRNA:decreased expression:colon mucosa (human) |
RGD |
PMID:9865741 |
RGD:11039405 |
NCBI chr 3:151,589,546...151,594,869
Ensembl chr 3:151,589,535...151,594,860
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
ISO |
DNA:SNPs:introns: (rs2280232, rs4327257) (human) |
RGD |
PMID:22121102 |
RGD:153323313 |
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
treatment |
ISO |
human cells in mouse model DNA:SNPs:introns: (rs12949918, rs6503695) (human) |
RGD |
PMID:32504672 PMID:22121102 |
RGD:125097526, RGD:153323313 |
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
ISO |
DNA:SNP:intron: (rs7217728) (human) |
RGD |
PMID:22121102 |
RGD:153323313 |
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
|
ISO |
DNA:SNPs:introns: (rs6503691, rs7218653) (human) |
RGD |
PMID:22121102 |
RGD:153323313 |
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
|
ISO |
DNA:SNP:3' utr: (rs324015) (human) |
RGD |
PMID:22121102 |
RGD:153323313 |
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
|
|
G |
Tert |
telomerase reverse transcriptase |
treatment |
ISO |
|
RGD |
PMID:19903903 |
RGD:11038656 |
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tet2 |
tet methylcytosine dioxygenase 2 |
|
ISO |
mRNA:increased expression:colorectum, Cancer Stem-like Cells (human) |
RGD |
PMID:31057717 |
RGD:150429686 |
NCBI chr 2:221,988,645...222,072,813
Ensembl chr 2:221,988,645...222,072,534
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
disease_progression |
ISO |
|
RGD |
PMID:9019169 |
RGD:13432089 |
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tp73 |
tumor protein p73 |
|
ISO |
mRNA:increased expression:colon (human) |
RGD |
PMID:30420492 |
RGD:151347580 |
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
|
|
G |
Ubr5 |
ubiquitin protein ligase E3 component n-recognin 5 |
ameliorates severity |
ISO |
human cell line in a mouse model |
RGD |
PMID:29296225 PMID:28856538 |
RGD:151665195, RGD:151665199 |
NCBI chr 7:69,115,216...69,224,843
Ensembl chr 7:69,116,761...69,224,903
|
|
G |
Vegfc |
vascular endothelial growth factor C |
|
IEP |
mRNA:increased expression:colon |
RGD |
PMID:18424890 |
RGD:2315488 |
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
|
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
|
ISO |
mRNA:increased expression:colon |
RGD |
PMID:29747153 |
RGD:126779566 |
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
susceptibility |
ISO |
DNA:polymorphism: :3435C>T (human) |
RGD |
PMID:16107775 |
RGD:2312343 |
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
|
IDA |
|
RGD |
PMID:16619498 |
RGD:1598563 |
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Arpc2 |
actin related protein 2/3 complex, subunit 2 |
|
ISO |
mRNA:decreased expression:colonic mucosa (human) |
RGD |
PMID:25107436 |
RGD:11049173 |
NCBI chr 9:75,820,782...75,851,471
Ensembl chr 9:75,820,770...75,851,471
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
|
ISO |
protein:increased expression:colonic mucosa (human) |
RGD |
PMID:8625322 |
RGD:11353854 |
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l2 |
Bcl2-like 2 |
disease_progression |
ISO |
|
RGD |
PMID:10638987 |
RGD:14394422 |
NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
|
|
G |
Birc7 |
baculoviral IAP repeat-containing 7 |
|
ISO |
|
RGD |
PMID:21122381 |
RGD:13217408 |
NCBI chr 3:168,047,824...168,052,606
Ensembl chr 3:168,047,824...168,052,606
|
|
G |
Borcs5 |
BLOC-1 related complex subunit 5 |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs3803098) A>G (human) |
RGD |
PMID:27354594 |
RGD:152177496 |
NCBI chr 4:167,458,640...167,543,556
Ensembl chr 4:167,473,177...167,540,993
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
disease_progression |
ISO |
|
RGD |
PMID:24500602 |
RGD:11567230 |
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Brd8 |
bromodomain containing 8 |
disease_progression |
IEP |
|
RGD |
PMID:19787264 |
RGD:9587763 |
NCBI chr18:26,204,892...26,229,999
Ensembl chr18:26,181,732...26,229,884
|
|
G |
Car12 |
carbonic anhydrase 12 |
severity |
ISO |
|
RGD |
PMID:10666387 |
RGD:155226866 |
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Ccdc17 |
coiled-coil domain containing 17 |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs2275085) T>C (human) |
RGD |
PMID:27354594 |
RGD:152177496 |
NCBI chr 5:130,051,158...130,056,676
Ensembl chr 5:130,045,938...130,056,673
|
|
G |
Cd44 |
CD44 molecule |
disease_progression |
ISO |
mRNA, protein:splice variant, increased expression:large intestine |
RGD |
PMID:16425351 |
RGD:2289356 |
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
susceptibility |
ISO |
DNA:SNPs:enhancers: (rs6013897, rs158552, rs17217119) (human) |
RGD |
PMID:28009432 |
RGD:151665179 |
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp4f6 |
cytochrome P450, family 4, subfamily f, polypeptide 6 |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs2283606) T>C (human) |
RGD |
PMID:27354594 |
RGD:152177496 |
NCBI chr 7:12,030,276...12,058,020
Ensembl chr 7:12,030,301...12,057,782
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
susceptibility |
ISO |
DNA:SNP: : 39179G>T(human) |
RGD |
PMID:19626461 |
RGD:9589082 |
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Dok3 |
docking protein 3 |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs2279398) (human) |
RGD |
PMID:27354594 |
RGD:152177496 |
NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188
|
|
G |
Emx2 |
empty spiracles homeobox 2 |
exacerbates |
ISO |
mRNA:decreased expression:colorectal mucosa (human) |
RGD |
PMID:28830374 |
RGD:153323301 |
NCBI chr 1:258,626,584...258,633,594
Ensembl chr 1:258,626,584...258,633,594
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
severity |
ISO |
|
RGD |
PMID:16507107 |
RGD:126781766 |
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
|
ISO |
mRNA:decreased expression:colorectum (human) |
RGD |
PMID:22966016 |
RGD:155598682 |
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
disease_progression |
ISO |
DNA:SNP: rs3757441 (human) |
RGD |
PMID:21926398 |
RGD:126779594 |
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
Fam151a |
family with sequence similarity 151, member A |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs11206394) G>C (human) |
RGD |
PMID:27354594 |
RGD:152177496 |
NCBI chr 5:121,514,804...121,527,555
Ensembl chr 5:121,514,804...121,527,555
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
treatment |
ISO |
human cell line in a mouse model |
RGD |
PMID:31255687 |
RGD:155663557 |
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Flt3 |
Fms related receptor tyrosine kinase 3 |
severity |
ISO |
DNA:polymorphisms:multiple |
RGD |
PMID:33075166 |
RGD:149735513 |
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
|
RGD |
PMID:8264230 |
RGD:13210753 |
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gata6 |
GATA binding protein 6 |
severity |
ISO |
human cells in a mouse model |
RGD |
PMID:24452072 |
RGD:13208874 |
NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532
|
|
G |
Gjb3 |
gap junction protein, beta 3 |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs9118) C>G (human) |
RGD |
PMID:27354594 |
RGD:152177496 |
NCBI chr 5:139,649,227...139,654,970
Ensembl chr 5:139,649,195...139,654,980
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
susceptibility |
ISO |
DNA:SNP:3' utr:c.718T>C (human) |
RGD |
PMID:18850177 |
RGD:152998895 |
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
ISO |
|
RGD |
PMID:21609933 |
RGD:13210767 |
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
|
RGD |
PMID:12421502 |
RGD:14700996 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
onset |
ISO |
|
RGD |
PMID:12421502 PMID:12682546 |
RGD:14700996, RGD:14701003 |
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Hpca |
hippocalcin |
severity |
ISO |
mRNA, protein:increased expression:colon carcinoma (human) |
RGD |
PMID:22696308 |
RGD:9693683 |
NCBI chr 5:141,455,616...141,466,252
Ensembl chr 5:141,455,613...141,463,841
|
|
G |
Ier2 |
immediate early response 2 |
disease_progression |
ISO |
protein:increased expression:colon (human) |
RGD |
PMID:22120713 |
RGD:153323322 |
NCBI chr19:23,494,551...23,496,075
Ensembl chr19:23,494,184...23,499,211
|
|
G |
Il16 |
interleukin 16 |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs1131445) T>C (human) |
RGD |
PMID:27354594 |
RGD:152177496 |
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
|
RGD |
PMID:8264230 |
RGD:13210753 |
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
protein:increased expression:colorectal mucosa (human) |
RGD |
PMID:10874008 |
RGD:151347670 |
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kcnh1 |
potassium voltage-gated channel subfamily H member 1 |
severity |
ISO |
DNA:amplification: (human) |
RGD |
PMID:17289873 |
RGD:9693694 |
NCBI chr13:103,722,140...104,024,762
Ensembl chr13:103,722,245...104,024,740
|
|
G |
Kdr |
kinase insert domain receptor |
treatment severity |
ISO |
protein:altered phosphorylation:colon |
RGD |
PMID:26325365 PMID:25372416 |
RGD:11529678, RGD:126848811 |
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Kmt2b |
lysine methyltransferase 2B |
|
ISO |
human gene in a mouse model |
RGD |
PMID:22713656 |
RGD:9588601 |
NCBI chr 1:85,821,700...85,840,987
Ensembl chr 1:85,821,753...85,841,326
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
treatment |
ISO |
|
RGD |
PMID:25405740 |
RGD:13210782 |
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
treatment |
ISO |
|
RGD |
PMID:25405740 |
RGD:13210782 |
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
|
RGD |
PMID:21122381 |
RGD:13217408 |
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mir31 |
microRNA 31 |
|
ISO |
RNA:increased expression:blood serum (human) |
RGD |
PMID:21658006 |
RGD:152998938 |
NCBI chr 5:103,599,038...103,599,143
|
|
G |
Msh2 |
mutS homolog 2 |
disease_progression |
ISO |
|
RGD |
PMID:11604476 |
RGD:126790556 |
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
exacerbates |
ISO |
RNA:decreased expression:colon (human) |
RGD |
PMID:28533893 |
RGD:150540307 |
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
ISO |
protein:increased expression:colorectal mucosa (human) |
RGD |
PMID:19198856 |
RGD:153002579 |
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs3135499) C>A (human) |
RGD |
PMID:27354594 |
RGD:152177496 |
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
|
|
G |
Pcsk4 |
proprotein convertase subtilisin/kexin type 4 |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs1047854) C>T (human) |
RGD |
PMID:27354594 |
RGD:152177496 |
NCBI chr 7:9,381,366...9,389,589
Ensembl chr 7:9,381,361...9,389,585
|
|
G |
Rab24 |
RAB24, member RAS oncogene family |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs1128287) C>A (human) |
RGD |
PMID:27354594 |
RGD:152177496 |
NCBI chr17:9,308,471...9,310,553
Ensembl chr17:9,308,525...9,310,553
|
|
G |
Rac1 |
Rac family small GTPase 1 |
disease_progression |
ISO |
mRNA, protein:increased expression:colorectum (human) |
RGD |
PMID:30926638 |
RGD:155230818 |
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
|
ISO |
|
RGD |
PMID:21122381 |
RGD:13217408 |
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rgs5 |
regulator of G-protein signaling 5 |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs15049) C>A (human) |
RGD |
PMID:27354594 |
RGD:152177496 |
NCBI chr13:81,848,254...81,885,053
Ensembl chr13:81,836,304...81,885,518
|
|
G |
Rictor |
RPTOR independent companion of MTOR, complex 2 |
disease_progression |
ISO |
protein:increased expression:colon (human) |
RGD |
PMID:27729429 |
RGD:152995521 |
NCBI chr 2:55,811,877...55,903,893
Ensembl chr 2:55,811,322...55,901,426
|
|
G |
Rnaset2 |
ribonuclease T2 |
|
ISO |
human cells in mouse model |
RGD |
PMID:27014725 |
RGD:153002831 |
NCBI chr 1:52,576,344...52,603,151
Ensembl chr 1:52,585,929...52,603,147
|
|
G |
Rsph1 |
radial spoke head component 1 |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs2839531) T>C (human) |
RGD |
PMID:27354594 |
RGD:152177496 |
NCBI chr20:9,341,910...9,360,640
Ensembl chr20:9,341,913...9,360,640
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
|
ISO |
mRNA:increased expression:colon |
RGD |
PMID:29747153 |
RGD:126779566 |
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:32359697 |
RGD:151361139 |
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Smarcb1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 |
disease_progression |
ISO |
protein:decreased expression:colon, nucleus |
RGD |
PMID:27184481 |
RGD:127285648 |
NCBI chr20:12,741,164...12,763,616
Ensembl chr20:12,741,477...12,763,620
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
no_association |
ISO |
|
RGD |
PMID:25339048 |
RGD:150573690 |
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
disease_progression ameliorates |
ISO |
protein:increased expression:colorectum (human) human cells in a mouse model |
RGD |
PMID:21826656 PMID:23733954 |
RGD:153298931, RGD:11076784 |
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
|
|
G |
Stra6 |
signaling receptor and transporter of retinol STRA6 |
|
ISO |
mRNA:increased expression:colorectum (human) |
RGD |
PMID:11358845 |
RGD:155631271 |
NCBI chr 8:58,548,899...58,568,861
Ensembl chr 8:58,549,736...58,568,860
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
|
RGD |
PMID:8264230 |
RGD:13210753 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp73 |
tumor protein p73 |
exacerbates |
ISO |
protein:increased expression:colon (human) |
RGD |
PMID:19956069 |
RGD:151347585 |
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
|
|
G |
Tpst1 |
tyrosylprotein sulfotransferase 1 |
susceptibility |
ISO |
DNA:SNP:3'utr: (rs3757417) G>T (human) |
RGD |
PMID:27354594 |
RGD:152177496 |
NCBI chr12:26,544,536...26,605,706
Ensembl chr12:26,544,536...26,605,704
|
|
G |
Tyms |
thymidylate synthetase |
|
IEP |
protein:increased activity:colon (rat) |
RGD |
PMID:10226549 |
RGD:2317418 |
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Utp23 |
UTP23, small subunit processome component |
susceptibility |
ISO |
DNA:missense mutation:cds:p.P215Q (rs16888728) (human) |
RGD |
PMID:26553438 |
RGD:11041896 |
NCBI chr 7:83,185,187...83,196,652
Ensembl chr 7:83,189,656...83,196,655
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
treatment |
ISO |
associated with Neoplasm Metastasis; DNA:missense mutation:cds: p.R399Q, c.1196G>A (human) |
RGD |
PMID:19908066 |
RGD:150573820 |
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
severity |
ISO |
DNA:mutations:multiple: |
RGD |
PMID:22522847 |
RGD:14402410 |
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8389152 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Bcar1 |
BCAR1 scaffold protein, Cas family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
|
|
G |
Car9 |
carbonic anhydrase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20526721 |
|
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Foxa1 |
forkhead box A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20526721 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
|
IDA |
|
RGD |
PMID:19322027 |
RGD:5686847 |
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20526721 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Spop |
speckle type BTB/POZ protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr10:80,358,121...80,438,983
Ensembl chr10:80,358,124...80,483,955
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15609129 |
|
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29295717 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
ISO |
protein:increased expression:myoepithelial cells: |
RGD |
PMID:16735089 |
RGD:10053629 |
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Ang |
angiogenin |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:15776477 |
RGD:2325702 |
NCBI chr15:24,312,711...24,323,361
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
protein:decreased expression:mammary gland |
RGD |
PMID:22323911 |
RGD:7421537 |
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Ar |
androgen receptor |
|
ISO |
|
RGD |
PMID:17543076 |
RGD:1643341 |
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Areg |
amphiregulin |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:8543395 |
RGD:2292664 |
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
disease_progression |
ISO |
|
RGD |
PMID:12628841 |
RGD:2289659 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
disease_progression |
ISO |
protein:increased expression:breast |
RGD |
PMID:16421596 |
RGD:2293106 |
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
|
ISO |
|
RGD |
PMID:14648660 |
RGD:7483575 |
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
treatment |
IEP |
|
RGD |
PMID:25861310 |
RGD:127284854 |
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
onset treatment |
ISO IEP |
DNA:missense mutation: :5972C>T |
RGD |
PMID:16280055 PMID:25861310 |
RGD:2289048, RGD:127284854 |
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Car9 |
carbonic anhydrase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20526721 |
|
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
|
|
G |
Casp6 |
caspase 6 |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:10574243 |
RGD:2301339 |
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
protein:decreased expression:breast |
RGD |
PMID:14612904 |
RGD:2289132 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
|
ISO |
DNA:hypermethylation:promoter, breast |
RGD |
PMID:14601057 |
RGD:2289156 |
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
disease_progression |
ISO |
protein:increased expression:breast |
RGD |
PMID:12628841 |
RGD:2289659 |
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
disease_progression |
ISO |
protein:increased expression:breast |
RGD |
PMID:15788662 PMID:17119686 |
RGD:2289981, RGD:2289931 |
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
|
ISO |
|
RGD |
PMID:9470844 |
RGD:2289952 |
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
disease_progression |
ISO |
|
RGD |
PMID:15788662 |
RGD:2289981 |
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
|
ISO |
associated with Carcinoma, Ductal, Breast |
RGD |
PMID:15841074 |
RGD:2289965 |
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
|
ISO |
mRNA, protein:increased expression:breast |
RGD |
PMID:17254320 |
RGD:2293756 |
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
protein:altered localization:nucleus CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:20526721 PMID:16080559 |
RGD:2306227 |
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hoxb13 |
homeo box B13 |
|
ISO |
DNA:hypermethylation |
RGD |
PMID:19250546 |
RGD:2314726 |
NCBI chr10:81,160,498...81,162,777
Ensembl chr10:81,160,498...81,162,777
|
|
G |
Klk10 |
kallikrein related-peptidase 10 |
disease_progression |
ISO |
mRNA:decreased expression:breast |
RGD |
PMID:12788170 |
RGD:2314849 |
NCBI chr 1:94,234,536...94,239,369
Ensembl chr 1:94,235,096...94,239,376
|
|
G |
Ldhb |
lactate dehydrogenase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23437403 |
|
NCBI chr 4:175,428,382...175,446,403
Ensembl chr 4:175,428,385...175,446,403
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:17642161 |
RGD:2290392 |
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:breast |
RGD |
PMID:14744773 |
| |